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Abstract 
In the treatment of periodontal defects, composite and asymmetric membranes might be applied to 
protect the injured area and simultaneously stimulate distinct tissue regeneration. This work describes 
the development and characterization of poly(D,L-lactic acid)/Bioglass® (PDLLA/BG) membranes with 
asymmetric bioactivity, prepared by an adjusted solvent casting method that promoted a non-uniform 
distribution of the inorganic component along the membrane thickness. We hypothesized that an 
improvement on structural and osteoconductive properties of the composite membranes would occur 
by the addition of BG, comparing to the pure PDLLA ones. To test this hypothesis a wide range of 
assays was performed.  
In vitro asymmetric bioactive behavior was proved. SEM micrographs revealed the smoothness of 
pure PDLLA membranes surface contrasting to the homogeneous asperities distribution of BG on the 
composite membranes bottom side surface, in which was exhibited an apatite layer upon immersion in 
simulated body fluid. The detection of BG presence was complemented by FT-IR spectra analysis. 
Owing to the BG microparticles hydrophilicity, an enhancement on swelling ratio would be expected by 
their incorporation on the membranes. Such result was no significantly visible, which may have been 
influenced by the weight loss induced through BG dissolution in PBS, and which percentage was 
consequently statistically higher for PDLLA/BG membranes. Such process is consistent with the 
abovementioned event of the formation of an apatite layer. The mechanical properties of the 
membranes were not significantly compromised with the introduction of BG. Revealing that this 
formulation maintains the necessary integrity for the membranes function. 
Human bone marrow stromal cells (hBMSC) and human periodontal ligament cells (hPDL) were 
seeded in osteogenic medium on the membranes surface, such as the ideally cell culture choice for the 
assessment of biological performance, respectively concerning to alveolar bone and periodontal 
ligament tissues. SEM observation, DNA content and metabolic activity quantification revealed an 
improved cell adhesion and proliferation for the PDLLA/BG membranes. A significant enhancement on 
cell differentiation was further detected by the measurement of APL activity, as well as a promoted 
mineralization, an extended extracellular matrix (ECM) and calcium nodule formation, suggesting the 
positive effect of the BG microparticles added. These last results were confirmed by both Ca content 
measurement and Von Kossa staining assays. Accordingly, from this formulation is expected a higher 
and even better regeneration of the abovementioned tissues. The results indicate that the proposed 
asymmetric PDLLA/BG membranes could have potential to be used in guided tissue regeneration 
therapies or in orthopaedic applications, with improved outcomes.  
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Resumo 
No tratamento de defeitos periodontais, a utilização de membranas compósitas de design 
assimétrico deve ser aplicada de forma a proteger a área afectada e, simultaneamente, estimular a 
regeneração de tecidos distintos. Este estudo descreve o desenvolvimento e caracterização de 
membranas de poli(D,L-ácido láctico) (PDLLA) e biovidro (BG, do comercial Bioglass®) com 
bioactividade assimétrica, através de um método ajustado de evaporação de solvente que permitiu uma 
distribuição não-uniforme da componente inorgânica ao longa da espessura da membrana. Hipotetizou-
se que um melhoramento das propriedades estruturais e osteoconductivas das membranas compósitas 
ocorreria graças à adição do BG, comparativamente às de PDLLA puro. Para testar esta hipótese, um 
alargado leque de testes foi aplicado. 
O carácter bioactivo assimétrico foi comprovado in vitro. Micrografias SEM revelaram a suavidade da 
superfície das membranas de PDLLA puro, contrastante com a homogénea distribuição de asperidades 
do BG à superfície da face inferior das membranas compósitas, na qual foi exibida uma camada de 
apatite, após imersão em SBF. A detecção da presença de BG foi complementada por análise dos 
espectros FT-IR. Graças à hidrofilicidade do BG, seria de esperar um aumento da razão de dilatação 
pela sua incorporação nas membranas. Tal não foi visível significativamente, podendo ter sofrido 
influência da perda de peso que a dissolução do BG em PBS provoca e cuja percentagem, por 
conseguinte, se revelou estatisticamente superior para as membranas de PDLLA/BG. Este processo é 
consistente com o evento de formação da camada de apatite, acima mencionado. As propriedades 
mecânicas das membranas não foram significativamente comprometidas com a introdução do BG. 
Revelando esta ser uma formulação que mantém a integridade exigida à função da membrana. 
Células humanas do estroma da medula óssea (hBMSC) e células humanas do ligamento 
periodontal (hPDL) foram cultivadas em meio osteogénico na superfície das membranas, como sendo a 
cultura celular ideal para a avaliação da performance biológica, no que respeita a tecidos como osso 
alveolar e ligamento periodontal, respectivamente. A observação SEM, bem como a quantificação do 
conteúdo em DNA e da actividade metabólica acusaram adesão e proliferação celular superiores nas 
membranas de PDLLA/BG. Um melhoramento significativo da diferenciação celular foi ulteriormente 
detectado por mensuração da actividade ALP, assim como uma promovida mineralização e extensa 
formação de matriz extra-celular e nódulos cálcicos, sugerindo o efeito positivo da adição do BG, 
confirmado inclusive por medição do conteúdo em Cálcio e procedimento Von Kossa. De acordo com 
estes resultados, desta formulação espera-se uma maior e melhor regeneração dos tecidos visados. Os 
resultados indicam que as membranas assimétricas de PDLLA/BG propostas podem ter potencial êxito 
se utilizadas em terapias de regeneração guiada de tecidos ou em aplicações ortopédicas.  
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1| Motivation and Outline 
Periodontal defect exists when tooth-supporting tissues, including the alveolar bone, periodontal 
ligament and cementum destruction occurs, as a consequence of periodontitis. [1] Mechanical 
removing of the damaged structures is the first procedure applied [2], however it is usually followed by 
a surgical intervention. [3] These conventional therapies reveal to be efficient in halting the periodontal 
disease progression; even so they involve some drawbacks that restrict their efficiency, being the major 
limitation related to the promotion of tissue regeneration. It is crucial to repopulate the defect with 
viable specific cells which are able to promote the regeneration of periodontal ligament and alveolar 
bone, as well as do not allow the growth of undesirable tissues, which cells have a higher migration rate 
[4; 5]. Considering that, regenerative procedures appeared using physical barrier membranes to create 
a segregated space and reach the aforementioned cell manipulation, which is often referred to as 
guided tissue regeneration (GTR). 
Periodontal defects can be a complex problem to treat and represents the main cause of tooth loss 
in adults. [1] Accordingly, although originally GTR membranes were used specifically for periodontal 
regeneration, they were afterwards introduced in the implants surgery field, to regenerate bone tissue 
and thus allowing the dental implants application and conferring the needed stability for the implants 
[6; 7]. This evolution has to be congruent with the emergent raise of implantology cases, nowadays, 
factor that more impulses the development of new membranes systems. In this case, the major 
challenge is the distinct tissue regeneration [8]. Combine bioactive ceramic or glasses with polymers, 
conferring an asymmetric bioactivity, seems to be a really promising option. 
Poly(D,L-lactic acid), PDLLA, is a biodegradable and biocompatible polymer that could be adequate 
to be used as the matrix in the production of membranes. The polymer may be formulated with 
inorganic particles and processed into membranes using different techniques. Bioglass® is an 
approved osteoconductive biomaterial used in orthopedic and dental applications. Therefore, the aim of 
this work was to prepare a PDLLA membrane containing Bioglass® microparticles, hypothesizing that 
these microparticles could enhance structural and biological performance of PDLLA membranes, 
regarding to periodontal regeneration. Moreover, due to the distinct biological environment 
experimented in vivo by the two sides of an implanted membrane, it seems reasonable to produce 
membranes with distinct properties in each face. To test this hypothesis, asymmetric PDLLA/Bioglass® 
membranes were prepared, in a single step, by an adjusted solvent casting method. 
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4 
This concrete chapter presents an overview of the guided tissue regeneration field, specifically 
applied to periodontal defects regeneration, as well as an additional analysis to the performance of 
poly(D,L-lactic acid) and Bioglass® in this area. 
 
2| Periodontal Defects 
Teeth anatomy involves a variety of different components, which can be classified as hard or soft 
tissues. We can identify three structural different layers in the tooth: enamel, dentine and pulp 
chamber. Enamel is a crystalline structure, extremely 
hard and highly mineralized, thus it is the outer layer 
and its function is to cover and protect the crown of 
the tooth. Dentine constitutes the core structure and 
pulp chamber composes the center of the tooth. 
Containing this center area, there are blood vessels 
and nerves, which connects the jaws vascular and the 
nervous supply through tooth apices. The tooth root is 
attached to the adjacent alveolar bone by the 
periodontal ligament. [9] 
Periodontal ligament is the investing and supporting connective tissue structure that anchors a tooth 
within its alveolus. It is composed by collagen fibers that connect the cementum of the tooth to both 
gingival and alveolar bone and to the cementum of surrounding teeth. [10]  
The etiology of periodontal diseases is related to the dental biofilm, of which evolution results in a 
progressive loss of dental insertion. [11] The presence of many bacteria in the supra and sub-gingival 
plaque was considered the major etiologic factor, and the accumulation of many microorganisms on it 
promotes the starting of periodontal destruction and consequent progression of the disease. [11; 12] 
Later on, the same author [13] revealed that inclusively some metabolic properties of dental biofilm 
assure the resistance of microorganisms to the natural body defenses. Logically, besides the bacterial 
intervention, aspects as genetic influences, immune host response and environmental factors are also 
included in the contribution for bacteria accumulation on gingival plaque and consequently in the 
progress of periodontitis.  
Periodontitis is a disease, which destroys the tooth-supporting tissues, including the alveolar bone, 
periodontal ligament (PDL) and cementum, creating defects in the oral cavity. This is the major cause of 
tooth loss in adults. [1] The treatment of periodontal defects can be a complex process. 
Figure 1.1 – Tooth anatomy and different distinguished 
structures. (Adapted from [9]) 
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Figure 1.2 – Periodontal disease. (A) A case of advanced periodontitis, evidencing very swollen gums, 
loose teeth, staining and heavy plaque and calculus deposits on all the teeth. (B) Tartar deposits on the 
inside aspect of the lower incisor teeth in a patient with periodontitis. (Adapted from [14]) 
 
2.1 Current Therapies and Outcomes 
Periodontal therapy mainly pretends to achieve reduction or even elimination of the tissue 
inflammation induced by the dental biofilm and correction of the anatomic defects, reestablishing the 
dental insertion integrity like before the disease. [15] 
The mechanical regular removing of dental biofilm (as well as calculus, infected cementum, 
granulated tissue and crown portion of epithelium) is the first procedure applied. [2] After an evaluation 
of the initial phase outcomes, if the inflammation signs persist, the surgical treatment emerges as the 
best option. [3] Therefore, conventional periodontal therapy includes not just nonsurgical (debridement 
of root surfaces or root canals) but also surgical approaches (periodontal flap procedures, recessive 
surgeries). These last mentioned ones provide a better access for the cleaning of root surfaces and 
apical lesions, as well as for restoring the surrounding bone/root apex. [16]  
Traditional recessive surgeries reveal to be efficient even for advanced disease stages, halting the 
periodontal disease progression, which is a good outcome once that allows and makes easy the 
removing of subgingival deposits, restituting the morphology of sustaining and recovering periodontal 
tissues. On the other hand, soft tissue recession, leading to poor esthetics in the anterior dentition, and 
residual pockets usually inaccessible to adequate cleaning, which negatively affect lon-term prognosis of 
the treated tooth, constitute the major drawbacks of this technique. [8] Nonetheless, the principal 
limitation of conventional therapies concerns to the promotion of periodontal regeneration. [17] 
Regeneration is though the most desirable but also the most difficult outcome for any therapy. [16] 
Considering the overcoming of these limitations and difficult challenges, new approaches such as 
regenerative techniques have been proposed. The main goal is the inhibition of undesirable tissues 
growth, essentially epithelial tissue which migration and growth rate is higher (approximately 10 times 
faster) than conjunctive and bone tissues, dominating the initial healing phase. [18] According to that, it 
(A) (B) 
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is crucial to colonize the defect with viable specific cells which are able to promote the periodontal 
regeneration. [7; 18] This concept is named compartmentalization and was introduced by Melcher in 
1976. [7] Thus, regenerative procedures used physical barrier mechanisms to reach the 
aforementioned cell manipulation, which is often referred to as guided tissue regeneration (GTR).  
GTR is specifically indicated for narrow intrabony and class II mandibular defects treatment, because 
the close proximity, between the defect and periodontal mesenchymal cell sources, allow their adequate 
migration, repopulation and differentiation into the defect. Based on the extensively proved concept that 
the ability to recreate the original periodontal attachment belongs only to the fibroblasts from the 
periodontal ligament or undifferentiated mesenchymal cells, GTR therapy was applied with success in 
the regeneration of periodontal defects. [8] Regarding to the furcation lesions, just for the treatment of 
class II mandibular furcations GTR can be effectively used, actually allowing the passage of class II into 
a class I mandibular furcation, easier to maintain overtime. However, on class II maxillary furcations it 
has a limited clinical effect (namely reduction in the horizontal furcation depth) doubtful clinical 
significant. [19] In respect to class III furcations, GTR efficacy is unpredictable. [19; 20] In the 
treatment of intrabony defects, apart from the high variability in clinical outcomes, GTR results show 
greater probing depth reductions and higher gain in attachment levels compared to conventional flap 
procedures. [21] 
Behind the successful GTR strategy to regenerate periodontal defects, many factors can influence 
the clinical responses to GTR. For example, the majority of patient-related factors such as smoking and 
residual periodontal disease could be controlled trough behavioral and therapeutic interventions [8], 
respectively. Several patient and local factors, as well as factors related to the surgical treatment that 
should be evaluated are listed on Table 1.1 and contribute for the increasing of the predictability and 
success of outcoming results of GTR.  
 
Table 1.1 – Factors that negatively influence guided tissue regeneration outcomes. (Adapted from [8; 16]) 
 
FACTORS INFLUENCE ON THE OUTCOMES 
P
AT
IE
N
T 
Smoking habit 
Decreased vascular flow, altered neutrophil function, and 
impaired fibroblast function, increased prevalence of 
periodontal pathogens, decreased IgG production and 
lymphocyte proliferation. 
Poor plaque control 
Residual periodontal disease 
Increased residual periodontal pockets and percentage of 
sites with bleeding. Higher risk of membrane 
contamination.  
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Table 1.1 (continuation) – Factors that negatively influence guided tissue regeneration outcomes. (Adapted from [8; 16]) 
 FACTORS INFLUENCE ON THE OUTCOMES 
P
AT
IE
N
T 
Systemic compromised patient 
Occlusal trauma 
Poor oral hygiene/compliance 
Mechanical trauma (aggressive tooth brushing) 
Inflamed gingival tissues 
Immunosuppression 
Diabetes 
Stress 
These ones were also cited as negative factors to the 
clinical outcomes of GTR, however the evidences are not 
enough. 
LO
C
AL
 
Local anatomy and morphology strongly affect the predictability of GTR. 
Case selection 
Increased residual periodontal pockets and percentage of 
sites with bleeding represent a higher risk of membrane 
contamination. 
Gingival thickness (if less than 1 mm) 
Increased prevalence and severity of flap dehiscence over 
GTR membranes. 
Calculus 
Overhanging restorations 
Favored plaque accumulation. 
Shallow infrabony defects 
Wide defect angle > 45 degrees 
Horizontal bone loss 
< 3-wall defects 
Deep furcation involvement 
Many studies have related significantly better results for 
GTR strategy than control groups (without GTR 
membranes) conjugated with the highest success rate for 
3-wall defects with a deep infrabony component of ≥ 4 
mm and defect angle < 45 degrees.  
SU
R
G
ER
Y 
Excessive flap tension 
Early mechanical disruption 
Contamination during surgery 
Lengthy/traumatic surgery 
Inadequate wound closure 
Poorly designed incisions 
Membrane exposure 
Basically, to achieve predictable tissue regeneration, 4 
summarized factors are critical (the so-called PASS [22]): 
primary wound closure; angiogenesis as a blood supply 
and source of undifferentiated mesenchymal cells; space 
maintenance; and, finally, stability of the wound. 
 
 
After the GTR procedures some postoperative care and maintenance are also required. Systemic 
antibiotics and nonsteroidal analgesics may be prescribed, either to reduce the risk of infection or to 
control pain. [8] Even the usual mechanical tooth cleaning should be avoided. If a non-resorbable 
membrane is used, it is needed a second surgical intervention, and, ultimately, if the postsurgical 
problems extend (e.g. membrane exposure as referred in Table 1.1) membrane has to be removed 
earlier. Membrane exposure frequency can vary between 50% and 100% and represents the major 
complication associated to the GTR strategy. [20; 23] To contour this drawback, the use of 
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bioabsorbable membranes has contributed and novel access flaps are introduced to preserve the 
interdental tissues, thus reducing the prevalence of membrane exposure. [8; 16] Actually, and 
unfortunately, GTR technique complications are frequent and play a negative effect on clinical 
outcomes, namely: bleeding, swelling, hematoma, erythema, suppuration, sloughing or perforation of 
the flap, membrane exfoliation and postoperative pain. [8] 
In order to overcome some undesirable outcomes and complications, combining therapies appeared 
as a solution. The use of barrier membranes parallel to the placement of bone grafting materials came 
up and should be able to ensure clot stabilization and prevent the membrane collapse into the defect 
[24]. 
 
 
3| Periodontal Defects and Guided Tissue Regeneration 
Nowadays, the main goals in the treatment of periodontal diseases are to regenerate periodontal 
tissue and to confer support to the bone tissue. Specific cells present in the periodontal tissue are able 
to produce a new periodontal ligament, cementum (tissue that involves the tooth root) and alveolar 
bone, if these components can migrate to the host local. The aim of GTR technique is to avoid the 
migration of epithelial cells to the lesion and, with the help of a membrane, create a physical space 
between the membrane and the bone. This space allows enough time for the formation of the new 
periodontal ligament, cementum and bone tissues, with the intention of the total affected area 
regeneration. The space created, specifically for the invasion of blood vessels and osteoprogenitor cells, 
protects the bone regeneration against the growth of non-osteogenic tissues, which have a higher 
migration rate. [4; 5; 25] Due to this dissimilarity on migration rates, soft tissues would grow in bone 
tissue’s place, if the barrier would not exist. Thus, the employment of a barrier membrane is to guide 
the new bone growth where volume and dimension are not enough for its normal function.  
Originally, GTR membranes were used specifically for periodontal regeneration, being afterwards 
introduced in the implants surgery field, to regenerate bone tissue in primary or secondary bone 
deficiencies. Primary bone insufficiency is prior to the implants integration and can follow two 
therapeutic procedures: insert simultaneously the implants and the membrane with or without grafts, or 
proceed in two steps, firstly getting a higher bone volume with the membranes action, and then put the 
implants. If the bone lack is posterior (secondary) to the implants inserting, such as peri-implant 
defects, fenestrations or dehiscence, membranes are implanted in order to restore the lost initial bone 
height. [26] These techniques are denominated as Guided Bone Regeneration (GBR). 
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GBR involves the GTR principles, being specifically directed to the alveolar bone reconstruction and 
thus allowing the dental implants application and conferring the needed stability for the implants. [6; 7] 
So, GBR is included in GTR, but is focused on the hard tissues regeneration (bone), instead of soft 
tissues. [27; 28] GBR has been extensively and fruitfully applied in the treatment of bone defects that 
are adjacent to the implants [29], once that the bone quantity is a crucial issue for the implant to 
succeed. In case of insufficient bone in the damaged area, implant cannot be totally engaged in the 
bone being in contact with soft tissues as gingival. It can lead to the soft tissue inflammation, which 
may result in the implant fail. These are the main reasons for the use of GBR in the dental implants 
application. [30; 31] Bone substitutes with osteoconductive properties [32] and growth factors [33; 34] 
were employed to promote bone growth, however, nowadays, the concept of bone regeneration is 
associated to membranes use. [35] 
 
 
4| Membranes for Guided Tissue Regeneration 
In this field the technique of GTR uses a membrane which acts as a physical barrier to protect the 
defect site and to prevent the epithelial cells, fibrous and gingival connective tissue to reach the injured 
area. This procedure favors the regeneration of lost and damaged tissue since it promotes cell 
repopulation of the periodontal ligament and adjacent alveolar bone. [36] Figure 1.2 illustrates the 
phenomena that occur during the progression of GTR membranes actuation in a periodontal defect, 
since its integration. 
 
 
   
 
Figure 1.3 – Progressive action of one of the guided tissue regeneration marketed membranes. (A) Adhesion 
of PDL fibroblasts to the smooth upper face, promoting soft tissue healing. (B) Osteoblasts adhesion to the 
rough porous bottom face, allowing increased mineralization. (C) Complete vascularization and porous 
interconnectivity, at 2 weeks. (Adapted from [37; 38]) 
 
 
(A) (B) 
(C) 
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The membranes application respects a rigorous surgical protocol. In general lines, first of all, the 
injured tissue has to be removed in order to prevent possible infections. Once created the propitious 
environment, the membrane is positioned between the alveolar bone and the periodontal ligament. 
Hence, the pretended bone regeneration occurs during which the biodegradable membrane is absorbed 
by metabolic processes. The membrane acts not just as a physical barrier preventing the fibroblasts 
invasion into the injured area, but also as a buffer that just allows the osteogenic potential cells 
presence and avoids their migration to the exterior area. This way the osteogenesis occurs with no 
difficults, such as an inefficient bone bonding or an incomplete recuperation of the original bone 
hardness. [4] 
Particularly in periodontal defects, the GTR technique is used to promote the conjunctive tissue 
adhesion to the tooth root surface, as well as to exclude the epithelial cells invasion from the injury. 
Additionally, it has been used to generate bone tissue around the implant, to avoid the fibrous 
encapsulation and to produce more bone tissue, thus enlarging the bone support. [4; 25] This space 
control, achieved by the use of membranes, permits also that the osteoblasts bone production occurs 
slowly with the aim of obtaining a better structural organization of the damaged tissue and, 
consequently, a more efficient healing. [25] 
First membranes were used in the 80’s. The real first ones were produced using expanded 
poly(tetrafluorethylene) (ePTFE). [39; 40] These membranes are not absorbed by metabolic processes. 
Still, ePTFE continued viable due to its biocompatibility and its use in vascular prosthesis. Although, this 
material presents many disadvantages such as: the regular exposition of the membrane after the 
implantation surgery, leading to the GTR fail and bacterial contamination; the need of a second surgical 
intervention to remove the membrane; and finally, after membrane removing, the exposure to the wear 
of new form bone. [6; 39] In order to overcome these limitations, biodegradable membranes have been 
introduced in the market [39]. Few characteristics are required to this kind of membranes. A 
description of membranes types, characteristics, materials and marketed products will be particularly 
described in the further sub-chapters. 
 
4.1 Properties and Characteristics 
GTR membranes should meet several properties to face the complex biological and sensitive system 
of the human body. Besides biocompatibility, barrier membranes should embrace physico-chemical and 
structural properties to guarantee basic, but complex and crucial conditions such as the ones described 
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in Table 1.2, in order to accomplish complete and perfect tissue integration. Non-toxicity, selective 
cellular occlusion and nutrients transfer are some of them. 
 
 
Table 1.2 – Membrane requirements for guided tissue regeneration and its correspondent description (information collected and adapted 
from [41-52]). 
  DESCRIPTION 
M
EM
B
R
AN
ES
 R
EQ
U
IR
EM
EN
TS
 
BIOCOMPATIBILITY 
NON-IMMUNOGENICITY 
NON-TOXICITY 
Ability to prevent and do not generate adverse inflammatory or 
immune response and to resist to bacterial invasion and 
colonization. 
BIODEGRADABILITY 
TOTAL RESORBABILITY 
To avoid second surgical procedure to remove the membrane. 
Absorption rate sufficient to maintain the physical barrier and at 
the same time compatible with the new bone formation. Total 
resorption of biomaterials, intended as a complete replacement 
of the foreign material by the regenerating tissues, appears still 
here as a perfect solution to interfacial problems. 
GOOD MECHANICAL 
INTEGRITY 
To maintain the desired shape and configuration, namely to 
provide a secluded space for bone regeneration. Need to be 
sufficient to support or match surrounding native tissue at site 
of implantation, as well as mediate mechanical stimulus to cell 
during loading. 
EASY HANDLING, 
CUTTING AND CONTOURING 
To allow the adaptation to the bone anatomy as well as an 
instant modeling by the professional (Dentist, Periodontologist, 
Implantologist) and consequent in site implantation of the 
membrane. 
MATERIAL ADHESIVENESS 
Adhesiveness between membrane and surrounding bone 
tissues to prevent movement of membrane. 
CELL ADHESION Optimization of cell seeding for retention of cells. 
SEMI-PERMEABLE Adequate porosity to allow nutrient and oxygen supplies. 
BIOACTIVITY 
To accelerate differentiation, mineralization and consequent 
bone formation. Eventually, to control the release of growth 
factors. 
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4.2 Types of Membranes 
GTR membranes have been extensively studied and many materials have been proposed for their 
fabrication. They can be provenient from natural or synthetic source, and are either bioabsorbable or 
nonresorbable. 
Both membranes classes reach the biological and mechanical aims defined for periodontal 
regeneration, inclusively above described on Table 1.2. Nevertheless, there is the risk of contamination, 
due to the membrane exposure after the first surgery. [53] Infections in the treated locals reduce the 
insertion gain and tissue regeneration, as well as accelerate the degradation process, though appeared 
the needing of a membrane not only with an ideal occlusion capacity but also with antimicrobial 
protection. [54] Facing that, resorbable membranes present a significant advantage, once they permit 
the incorporation of antimicrobian agents that can be released upon implantation. 
Moreover, generally, non-resorbable membranes have to be removed by a secondary surgical 
procedure after the tissue had formed, increasing the risk of patient infection and other undesirable side 
effects. Also, they cannot be used to reconstruct large bone defects due to its bioinert properties 
constituting a significant disadvantage [55; 44]. In order to overcome such drawback, bioresorbable 
membranes have been proposed. In this case the degradation of the membrane should not interfere 
with bone healing and, before osseous regeneration has taken place, degradation should not be 
completed [56; 57]. 
 
4.3 Materials Employed and Current Marketed Membranes 
Several membranes were studied and proposed for GTR. However, for a membrane to become 
commercially available there are many obstacles to overcome, such as the clinical evaluation and the 
approval by the competent regulatory agencies. After the membrane conception and in vitro 
characterization, preliminary studies in animals are performed; subsequently, the most trustable 
systems may be redirected to pre-clinical studies in humans. Clinical evaluation is such an important 
and exigent parameter. In consequence, only few have reached the stage of routine clinical application 
[58].  
Expanded poly(tetrafluoroethylene) (e-PTFE), silicone rubber or titanium are the materials that 
constitute most non-resorbable membranes. The bioresorbable ones have been produced using 
collagen, collagen with elastin, poly(L-lactic acid) (PLA), poly(L-lactic acid)-blend-poly(D, L-lactic acid) 
(PDLLA), poly(D,L-lactide-co-glycolide) (PLGA) or trimethylene-carbonate (TMC). [56; 59; 60] 
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Natural collagen membranes have been the mostly used, not just because collagen is one of the 
components of the alveolar bone and periodontal ligament but also because this material performs 
almost all the criteria mentioned in the previous paragraphs. [61] For example BioGide®, Bicon®, 
BioMend®, BioSorb® and Ossix® are some of the current collagen membranes in the market. 
However collagen presents some drawbacks, including fast resorption rate, cytotoxicity, poor 
mechanical strength and fast biodegradation by enzymatic activity. [61; 62] To decrease this 
degradation rate and increase its hardness, collagen could be enhanced with cross-linking techniques 
[63] but this procedure (particularly with glutaraldehyde) can inhibit the attachment and proliferation of 
human PDL and human osteoblastic cells. [38] Adding the fact that its xenogenic origin presents a risk 
of disease transmission between animals and humans [64] and also that collagen tends to lose the 
ability to keep its own shape in wet conditions, as those existing in the oral cavity, [65; 66] these 
problems concur to the searching for new solutions. 
 
 
Table 1.3 – Synthetic biodegradable marketed membranes, with respective constituent polymer, dimensions in mm, biodegradation time 
in weeks, price in Euros per unit and produced company. 
  POLYMER DIMENSION 
(mm) 
BIODEGRADATION 
TIME (weeks)1 
PRICE 
(€/unit) 
COMPANY 
 M
AR
K
ET
ED
 M
EM
B
R
AN
ES
 
Artisorb® [69] PLA - 9 – 12 - 
Citagenix, 
Canadá 
BioCellect™ [70] PLA 
15x20 
20x30 
4 – 8 
67  
100  
IMTEC 
Corporation, USA 
BioMesh® [71] 
PGA 
PLGA 
PLLA 
15x12 
17x17 
25x17 
30X24 
40X30 
25X20 
24 
70 
70 
70 
70 
106 
92 
Samyang’s, 
Daejeon, Coreia 
BioMesh-S® [71] 
PGA 
PLGA 
PLLA 
36 - 
EpiGuide® [69] 
D, D-L, L- 
PLA 
18x30 56 46 
Curasan Inc., 
USA 
Gore Resolut Adapt® [72] 
PGA 
TMC 
15x20 
20x25 
25x20 
 
> 10 150 W. L. Gore & 
Associates, Inc., 
Arizona, USA 
Gore Resolut Adapt LT® 
[72] 
PGA 
TMC 
25x30 > 24 158 
Inion® GTR™ [73] 
TMC 
PLA 
PGA 
30x40 > 12 96 
Inion Ltd, UK e 
USA 
1 Until complete bioresorption 
 
CHAPTER I. General Introduction 
14 
In order to avoid these undesirable characteristics, maintaining the desirable ones, synthetic 
materials have been more frequently used, predominantly the poly(α-hydroxyesters) family. [72] These 
materials are the gold standard in applications of biodegradables in medicine. The chemical properties 
of these polymers allow its hydrolytic degradation and removing by natural pathways. [68] Moreover 
their processing is easy compared to other polymers and the variety of existent molecular weights and 
copolymers permits a wide range of physical, mechanical and degradation rate related adjustments. 
Epi-Guide®, Gore Adapt®, Inion®, BioMesh® and BioCellect® are examples of current available 
marketed GTR membranes of this specific type, among many others described and analyzed in Table 
1.3. 
 
5| Biocomposite Materials 
First generation of biomaterials was developed to achieve exclusively bioinert tissue response. The 
forward generation emerged as bioactive biomaterials. Bioactivity is described as the capacity of the 
material to elicit a controlled action and reaction in the physiological environment. [74] 
Reinforcement of biodegradable polymers matrices to produce composites of tailored surface, 
chemical and mechanical properties is a desirable approach for potential biomedical applications, such 
as in the regeneration of hard or even soft tissues. [75] The increasing research efforts worldwide for 
bone tissue regeneration [73;76-88] are trying to fulfill as many requirements as possible. For example, 
inorganic phases of tricalcium phosphate [89], hydroxyapatite [90-92] or bioactive glasses [79; 93; 94] 
are included into biodegradable poly(α-hydroxyester)-based matrices, such as poly(lactic acid), 
poly(glycolic acid) and their copolymers, as a viable way to improve the abovementioned properties and 
enhance bioactivity. Actually, the possibility of counteracting the acidic degradation of biodegradable 
polymer by the use of bioactive glasses is another reason for the use of composites. [95-97] 
Consequently, composite systems combining advantages of biodegradable polymers and ceramics 
seem to be a really promising choice. 
 
5.1 Biodegradable Polymers, the Poly(α-hydroxy-esters) 
There are two types of biodegradable polymers taking into account their origin. The natural-based 
materials are one category, including starch, chitosan, alginate, hyaluronic acid derivatives (common 
polysaccharides) or collagen, fibrin gels, silk and soy (proteins). [98; 99] Synthetic biodegradable 
polymers constitute the second category: in general they may be obtained with high purity and 
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exhibiting predictable and reproducible mechanical and physical properties (elastic modulus, 
compressive or tensile strength and degradation rate) due to their under controlled production. [100-
103]  
Poly-α-hydroxy-esters are the most widely used biodegradable polymers for tissue engineering and 
regeneration inclusively have been approved by the US Food and Drug Administration for several 
applications. In these range are included poly(lactic acid) (PLA) and poly(glycolic acid) (PGA), as well as 
poly(lactic-co-glycolide) (PLGA) copolymers. PLA exists in three forms: L-PLA (PLLA), D-PLA (PDLA), and 
racemic mixture D,L-PLA (PDLLA). [68; 100; 104; 105] Table 1.4 describes some of these parameters 
for the cited polymers, which may however vary with molecular weight and crystallinity [106]: 
 
Table 1.4 – Physical properties of synthetic, biocompatible and biodegradable polymers from saturated aliphatic polyesters family used as 
scaffold materials. (Adapted from [75]) 
  
Tm (°C) Tg (°C) BIODEGRADATION 
TIME (months)1 
COMPRESSIVE*/TENSILE 
STRENGTH (MPa) 
MODULUS 
(GPa) 
P
O
LY
M
ER
S 
PDLLA 
Amorphous 55-60 12-16 Pellet: 35-150* 
Film/disk: 
1.9-2.4 
   Film/disk: 29-35  
PLLA 
173-178 60-65 >24 Pellet: 40-120* 
Film/disk: 
1.2-3.0 
   Film/disk: 28-50  
   Fibre: 870-2300 Fibre:10-16 
PGA 225-230 35-40 6-12 Fibre: 340-920 Fibre: 7-14 
PLGA Amorphous 45-55 Adjustable:1-12 41.4-55.2 1.4-2.8 
PCL 58 -72 >24 - - 
1 Until complete bioresorption 
 
The chemical nature of these polymers allow hydrolytic degradation. Human body already contains 
highly regulated mechanisms for the complete removing of monomeric components of lactic and 
glycolic acids, i.e., once degraded, they are removed by natural pathways. PLA is eliminated through 
the tricarboxylic acid cycle, while PGA is converted in metabolites or cleared by other mechanisms. [68] 
The in vivo degradation of these poly(α-hydroxy esters) occurs by hydrolysis, releasing the lactic or 
glycolic acids which are metabolized through the Krebs cycle into carbon dioxide (CO2) and water (H2O), 
basic human body elements. [72] Even though, the degradation kinetics is affected by different factors, 
such as: chemical composition and configurational structure, molar mass (Mw), polydispersity 
(Mw/Mn), environmental conditions, stress and strain, crystallinity, morphology (e.g. porosity) and 
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chain orientation, distribution of chemically reactive compounds within the matrix, additives, presence 
of original monomers, overall hydrophilicity and their processing history. [95; 96] 
In general, their processing is easy compared to other polymers and the various existent molecular 
weights and copolymers permit a wide range of adjustments, in respect to degradation rate, physical 
and mechanical properties. PLA is more hydrophobic than PGA due to the additional methyl group in 
the structure of PLA; therefore PGA degrades much more quickly (a few weeks [107; 108]) than PLA, 
which can remain stable for over 1 year [109], or more depending on its degree of crystallinity. Albeit, 
these polymers still have some drawbacks. Sometimes their bulk erosion can result in scaffolds 
premature fails and, for example, an abrupt release of these acidic degradation products can cause 
strong inflammatory responses, being the typical pH drop associated with PLA and PGA implants one of 
its major negative aspects. [110; 111]  
 
5.1.1 Poly (D,L-Lactic Acid) 
Poly (D,L-lactic acid), PDLLA, is the racemic polymer of the poly(lactic acid) family – see Figure 1.3, 
general chemical structure. It is originated by the chirality of carbon α that allows the synthesis of 
enantiomers composites: L and D. Due to the random distribution of L and D unities on the polymeric 
chain, PDLLA does not have crystalline domains, being an amorphous material with lower stiffness as 
compared to the semi-crystalline PLLA. Therefore, the hydrolysis of this amorphous polymer is faster 
due to the lack of crystalline regions. [112-114] 
 
 
Figure 1.4 – General chemical structure of poly(lactic acid). (Adapted from [112]) 
 
Li et al [115] studied a series of PDLLA copolymers, concluding that after 12 weeks of in vitro 
degradation in PBS, the material bulk suffers significant mass decrease, being these results 
concomitants with the in vivo results among other studies. [115] 
PDLLA shows excellent biocompatibility in vivo and high mechanical stability. [116; 117] Such 
excellent features of PDLLA with respect to implant performance have made itself an extensively 
investigated biomedical coating orthopedic material. [100; 118] Much more attention has been also 
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paid to PDLLA for applying it as a scaffold material for tissue engineering and regeneration. Desirable 
features such as the ability to combine with drugs like growth factors, antibiotics or thrombin inhibitor, 
establishing a locally acting drug-delivery system, are in the center of this interest. [118] 
 
5.2 Bioactive Ceramic phases 
Bioactive glasses and calcium phosphates have been largely applied in bioactive composite 
materials. Their excellent biocompatibility, as well as the possibility of counteracting the acidic 
degradation the ability of bone bonding are essential attributes for their choice. [119] 
After implantation in vivo or contact with biological fluids, bioactive glasses and ceramics develop on 
the surface a biologically active hydroxy-carbonate apatite (HCA) layer which provides the bonding 
interface with the local tissue. The HCA phase is structural and chemically equivalent to the bone 
mineral phase, providing interfacial bonding (bridging host tissue with implants [120]). This procedure 
is achievable in vitro using a protein-free and acellular simulated body fluid (SBF), which nearly has the 
exact ion concentration of human blood plasma. [121; 122] This time-dependent kinetic modification of 
the surface is a bon-bonding behavior referred to as bioactivity, the main characteristic of this kind of 
materials. [119; 121; 123-126] 
 
Table 1.5 – Mechanical properties of dense and highly porous 45S5 Bioglass®, hydroxyapatite, A/W glass-ceramic, and human cortical 
bone. (Adapted from [75]) 
  
COMPRESSIVE 
STRENGTH 
(MPa) 
TENSILE 
STRENGTH 
(MPa) 
ELASTIC 
MODULUS 
(GPa) 
FRACTURE 
TOUGHNESS 
(MPa   ) 
C
ER
AM
IC
S 
45S5Bioglass® ≈500 42 35 0.5 – 1 
Hydroxyapatite (HA) >400 ≈40 ≈100 ≈1.0 
Glass-ceramic A/W 1080 215 118 2.0 
Porous bioactive glass70S30C 
(82%) 
2.25 - - - 
Porous Bioglass® - derived 
glass-ceramic (>90%) 
0.2 – 0.4 - - - 
Porous HA (82-86%) 0.21 – 0.41 - 0.83 – 1.6 x 10-3 - 
 
Cortical Bone 130 – 180 50 – 151 12 – 18 6 – 8 
 
Cancellous bone 4 – 12 - 0.1 – 0.5 - 
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Table 1.5 gives summarized information related to the typical mechanical properties of different 
bioactive glasses and ceramics. Bioactive glass-ceramics exhibit better mechanical performance 
compared to amorphous glass and calcium phosphate. Nonetheless their low fracture toughness and 
mechanical strength are still a drawback, specially comparing to cortical and cancellous bone (Table 
1.5). [123; 127-130] 
It is recognized that a layer of biologically active HCA must form to occur the bonding with the bone 
tissue; in fact, this is the only common characteristic of all the known bioactive implant materials. [74] 
Starting in 1967, Hench [121; 122] has extensively studied bioactive glasses as well as bioactive glass-
ceramics. Although he could summarize the stages that are involved in the bone-bonding formation, 
some details remain yet indefinite. On the other hand, Hench was able to clearly define three classes of 
bioactive materials (A, B and C) characterized by the rate of bone regeneration and repair: materials 
that lead to both osteoconduction (the growth of bone along the bone-implant interface) and 
osteoproduction, as a result of the fast reactions on the implant surface, constitute the class A [131; 
132]; alternatively, class B bioactivity takes place when just osteoconduction occurs [133; 134]; and, 
finally, materials that are resorbed within 10-30 days in tissue are included in class C. [121] 
To emphasize the relevance of bioactive glasses there is the fact that they also have the ability to 
support enzyme activity [135-137], vascularization [138; 139], promote osteoblast adhesion, growth 
and differentiation, and induce mesenchymal cells differentiation into osteoblasts [85; 140; 141]. 
Furthermore, particularly for 45S5 Bioglass® composition, their dissolution products upregulate the 
gene expression that control osteogenesis and the growth factors production [142]. 
 
5.2.1 Bioglass® 
Bioglass® is a proven osteoconductive material.[121] Since it belongs to the bioactive glasses 
family, it encloses a reactive silicate surface which, when in contact with biological fluids, forms a layer 
of carbonated HA, a strong and adherent bond with bone. Particularly for 45S5 Bioglass® composition, 
this complex multi-stage process occurs very rapidly. [143; 144] Additionally, Wilson et al [126] 
demonstrated that further than its excellent bone-bonding properties, Bioglass® also forms a bond with 
soft connective tissues. 
In general, bioactive glasses contain SiO2, Na2O, CaO and P2O5. Specifically, for 45S5 Bioglass®, 45 
represents 45 wt% SiO2, S is the network former and 5 corresponds to the ratio of CaO to P2O5, with the 
rest weight percentage (around 24.5 wt%) correspondent to the Na2O portion. [75; 143; 144] This was 
the original basis composition selected for the first investigations of Hench et al. [121] respecting the 
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ternary eutectic showed by the equilibrium phase diagram 
Na2O–CaO–SiO2. However, further researches have been 
trying different wt% proportions, in order to improve the 
bioactivity of these bioactive glasses. For example, 45S5 
Bioglass® (see Figure 1.4), with 55% SiO2, exhibit a high 
bioactivity index and bond to both soft and hard tissues. 
[75] 
Bioglass® has been used as a reinforcing agent within 
polymer matrices, being expected to increase also 
mechanical properties of the composite. Stiffness and 
microhardness of high-density polyethylene composites 
was amplified with a reinforcement of filler volume fraction in Bioglass® particulates (melt blending, 
compounding, powdering and comprehension moulding techniques involved). [145] On the other hand, 
that cited positive reinforcing effect was not replicated in composites of poly(α-hydroxyesters). [93] The 
addition of bioactive glass (53 wt% SiO2) as a filler for poly(D,L-lactide) composites may reduce its 
modulus and strength in specimens assessed, both dry and wet conditions. [80; 93] Rich et al [97] 
evaluated the influence of the incorporation of small particles of bioactive glass into poly(ε-
caprolactone–co–D,L-lactide 96/4), concluding that it might accelerate the degradation of the 
composite. Although, it is important to state that high-temperature processing methods were involved, 
remaining to the possibility of the processing-temperature influence and consequent favor of the 
composite debilitation and faster degradation. Moreover, further studies have shown that the use of low-
temperature processing for poly(α-hydroxyesters) with Bioglass® may circumvent these problems [79; 
146], actually very recently, Blaker et al (2010) [144] proved it as well. 
The addition of Bioglass® to bioresorbable polymers allows a rapid exchange of protons in water for 
alkali in the glass, providing a pH buffering effect at the polymer surface and consequently modifying 
the acidic polymer degradation. [83; 147] Thus it has been proved that bioactive glasses interfere on 
the polymer degradation behavior. [148] Actually, the pH is just one among other adjustable 
parameters controlling the degradation kinetics, by the integration of bioactive glasses in polymer 
scaffolds. These materials also modify the surface and inclusively the bulk properties of composite 
scaffolds, by increasing the hydrophilicity and water absorption of the hydrophobic polymer matrices. In 
particular, 45S5 Bioglass® particles were found to increase water absorption when included in PDLLA 
[149] and PLGA [83; 147] polymer foams, compared to the pure ones.  
Figure 1.5 – SEM micrographs illustrating the typical 
―cauliflower‖ morphology of hydroxyapatite formed on 
the surface of a 45S5 Bioglass® based foam after 
immersion in SBF for 28 days. (Adapted from [151]) 
CHAPTER I. General Introduction 
20 
Depending on the particle size and processing technique, the surface reactions on bioactive glasses 
can release critical concentrations of soluble Si, Ca, P and Na ions, inducing intra and extracellular 
responses. [142; 150] Ideally, the degradation and resorption of composite scaffolds are designed to 
allow cells to proliferate and secrete their own extracellular matrix, while the scaffolds gradually vanish, 
leaving space for new cell and tissue growth. [75] Stimulation of neo-vascularization is also appointed 
as an ability of 45S5 Bioglass®. In some studies, scaffolds containing controlled concentrations of 
Bioglass® showed to increase secretion of vascular endothelial growth factor (VEGF) in vitro and to 
enhance vascularization in vivo. [75; 138] 
The entire aforementioned characteristics engaged by 45S5 Bioglass® made out it like a successful 
material for tissue regeneration. Their application extends since as scaffold materials, either as filler or 
coating of polymer structures [147; 151], or even as porous material involving melt-derived and sol-gel-
derived glasses [125]. Bioglass® implants have been applied in the replacement of damaged middle 
ear bones and restoring hearing to patients [125]. Concretely, the main applied area is the Dentistry, in 
which there are already marketed products, such as Perioglass™ for clinical treatment of periodontal 
disease and Novabone™ used as bone filler. [121] 
 
5.3 Bioactive Composites Processing Techniques 
Bioactive composites can be processed by different techniques. Injection or compression moulding 
and twin-screw extrusion, are typical melt-based processes. To obtain porous composite scaffolds, 
molding with leachable particulates, sintering of composite microspheres and gas foaming are also 
melt-based techniques that can be used. Contrasting, there are also low-temperature processes, such 
as thermally induced phase separation (TIPS), combined solvent casting and porogen leaching, solid 
freeform methods and certain gas foaming methods. [144] 
 
5.3.1 The Solvent Casting Method 
Solvent casting is used to process biocomposite materials. This processing involves the dissolution 
of the polymer in a solvent and the consequent casting of the solution into a predefined mold. Particles 
may be added to the solution, with specific dimensions. The mixture is molded in accordance with the 
pretended final geometry, which means that this solution can be either converted in membranes using 
a flat glass plate, or in 3D structures using an appropriate mold. Subsequently, the solvent evaporates 
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and the final composite structure contains the polymer and the added particulates (e.g. ceramic 
granules) and will exhibit the shape of the mold. [152; 153] 
This is an easy technique that does not need specialized equipment, which represents its main 
advantage. The porosity percentage and number of porous are parameters directly dependents on the 
particles quantity and dimension.[152] Other parameters involved are the polymer and solvent choosing 
[154] and mechanical properties, which are not very variable during the processing once that this 
technique does not use fusion process [155]. Nevertheless, solvent casting have some limitations: a) 
the variety of shapes, because, typically, just flat sheets are obtained; b) use of toxic solvents, 
possibiliting their retention within the polymer, and consequent interference on the quality and viability 
of the obtained samples; c) the denaturation of proteins and other molecules incorporated into the 
polymer by the use of some solvents that may decrease the activity of these bioinductive molecules. 
[153] 
 
6| Asymmetric Biocomposite Membranes 
Although many of membranes are commercially available, numerous studies continue to be 
developed in this area, in order to propose improved solutions. 
The aim of tissue regeneration processes is intrinsic to the similarities between the new regenerated 
tissue and the original one. Acting as physical barriers is such a limitation on the clinical effects of the 
GTR membranes, since they provide no biologic effects on proliferation and differentiation of 
mesenchymal and PDL cells, respectively concerning to bone and periodontal ligament regeneration. 
[8] Basically, each side of the membrane is in contact with a distinct biological environment, and 
consequently it claims that the osteointegration should be ideally promoted just in one of the faces. The 
development of membranes with asymmetric properties may constitute a new direction for GTR in 
periodontal tissues. 
GTR membranes with bioactivity properties have been studied in the last decade. In 2004, a poly(L-
lactic acid)/calcium carbonate hybrid membrane was proposed, exhibiting an in vitro precipitation of 
hydroxycarbonated apatite [156]. Zhang et al prepared another bioactive composite membrane based 
on PLA including a bioactive glass [157]. Hydroxyapatite was also used as the ceramic phase in a nano-
hydroxyapatite/collagen/poly(lactic acid)(PLA) membrane, where calcification was formed at the 
surface after immersion in simulated body fluid (SBF) [158]. A polycaprolactone/calcium-carbonate 
fibers composite membrane with osteoconductive properties was proposed [159]. Three layered nano-
carbonated hydroxyapatite/collagen/PLGA composite membranes were also reported, with improved 
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bioactive, mechanical and biochemical properties [44]. Composite membrane of poly(ε-caprolactone-co-
D,L-lactide), coated just in one side with bioactive S53P4 glass granules, induced the formation of a 
calcium-phosphate layer [160]. PCL reinforced with nanofibrous glass induced apatite-like precipitation 
on the surface, when immersed in SBF [161]. An electrospun PCL/nano-apatite composite membrane 
revealed the same bioactive potential [47]. A poly(lactic-co-glycolic acid) membrane grafted with 
hyaluronic acid bi-layer films demonstrated to promote angiogenesis due to its osteoconductive 
properties, acting distinctly in each face [162], among some other ones. Despite of all the work 
reported on asymmetric membranes, it is still necessary to develop new systems obtained by simple 
processes and characterized by a good integration between the layered constituents. 
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1| Materials 
Poly(D,L-lactic acid) (PDLLA), (Mn= 31750 and Mw= 100000) with an inherent viscosity of 1.87 dL/g 
was purchased from Purasorb® (PURAC Biochem, The Netherlands)  and was used as received. The 
45S5 Bioglass®, with the composition: 45 SiO2, 24.5 CaO, 24.5 Na2O and 6.0 P2O5 in wt%, was 
supplied by US Biomaterials Corp. (Florida, USA). The particle size of the Bioglass® particles (BG), 
measured by laser scattering analysis (Coulter LS 100 particle size analyzer), was found to be lower 
than 20 μm. All the other reagents and solvents used were of reagent grade and were used without 
further purification.  
 
2| Methods 
2.1 Preparation of PDLLA and Bioglass® Membranes 
All the membranes were prepared based on a solvent casting technique. The PDLLA films were 
prepared by dissolving 0.50 g of PDLLA in 30 mL of chloroform. After total dissolution, the solution was 
transferred to a Petri dish with 9 cm of diameter and covered with an aluminium sheet. The Petri dish 
was settled in a horizontal position to facilitate the formation of a cast film with uniform thickness. The 
assembly was kept in a hood for 24h, and chloroform was allowed to evaporate at a very slow rate. 
Then, the films were vacuum dried for 48h at 40ºC. 
The PDLLA/BG membranes were prepared in the exact same process as the pure PDLLA 
membranes. The PDLLA/BG dispersions were prepared by dissolving 0.40 g of PDLLA in 30 mL of 
chloroform. After total dissolution, 0.10 g of Bioglass® was dispersed in the above solution. During 
solvent evaporation the particles will preferentially deposit by gravity to the bottom side of the dispersion 
medium, creating in the end an asymmetric 80/20 of PDLLA/BG membrane along the thickness. 
 
2.2 Bioactivity Tests 
For the in vitro bioactivity tests an acellular simulated body fluid (SBF) (1.0x) with ions concentration 
nearly equal to human blood plasma was prepared [1]. Sample membranes of 20x15 mm2 were cut 
from the original processed films for the bioactivity tests. Three replicates for each sample were 
immersed in 45 mL SBF for 2, 5, 7, 14 and 21 days at 37ºC. After being removed from SBF the 
membranes were gently rinsed with distilled water and dried at room temperature. 
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2.3 Physico–chemical Characterization 
2.3.1 Scanning Electron Microscopy (SEM) 
Qualitative information of the morphology of PDLLA and PDLLA/BG membranes surfaces, after and 
before the immersion in SBF, was obtained using a Scanning Electron Microscope (Nova NanoSEM 
200-FEI Company) at an accelerated voltage of 5 kV. Before being observed by SEM, the membranes 
were gold coated using a Hitachi coating unit IB-2 coater at 6 mA. 
 
2.3.2 Fourier Transform Infrared Spectroscopy (FTIR) 
The possible formation of a CaP layer onto the surface of polymeric membranes incorporating the 
microparticles after 14 days soaking in SBF, was analysed by infrared spectroscopy where the 
background noise was calibrated with pure KBr data. Also, each side of the composite membrane were 
analysed with the attenuated total reflection accessory. Spectra were recorded in an IR Prestige 21 FTIR 
spectrophotometer with the attenuated total reflection accessory (128 scans, resolution 4 cm-1) in the 
spectral range 2000-400 cm-1. 
 
2.3.3 Swelling Properties 
The water sorption capacity of the membranes was determined by swelling the samples in 
phosphate buffered saline solutions (PBS, Gibco) at pH 7.4 for up to 4 months at 37°C. The initial 
weight of each membrane (approximately 10×10 mm2) was measured with an analytical balance 
(Scaltec, Germany) before immersion in the PBS for several pre-determined time intervals (5 min, 30 
min, 1 h, 1 day, 7, 14, 22, 28 days, then 6, 8, 12 weeks and finally 4 months) and immediately 
weighted after the removal of excess of water by lying the surfaces on a filter paper (Whatman 
Pergamyn Paper, 100×100 mm2). The swelling ratio (SR) was calculated using the following equation 
(1): 
    
     
  
            (1) 
 
Where    and    are the weights of the samples at the swelling state and at the dry state, 
respectively. 
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2.3.4 Degradation Test 
The degradation of both membranes (with or without BG microparticles) was evaluated by 
immersing samples (with known weights and approximately 10×10 mm2) in PBS, at pH 7.4 for 4 
months at 37°C. At pre-determined time intervals (5 min, 30 min, 1 h, 1 day, 7, 14, 22, 28 days, then 
6, 8, 12 weeks and, finally, 4 months) samples were removed from the solution and washed with 
distilled water three times for the removal of salts. The samples were dried at room temperature and 
then weighted with an analytical balance (Scaltec, Germany). The following equation (2) was used to 
calculate the percentage weight loss (%WL) of the samples: 
 
     
     
  
                        (2) 
 
Where    is the initial dry weight of the sample and    is the weight of the dry sample after 
incubation in the PBS solution. 
 
2.4 Mechanical Characterization 
2.4.1 Mechanical properties 
The tensile properties were determined using an INSTRON 4505 Universal Machine (Instron Int. 
Ltd., USA) equipped with a 1 kN load cell, with a loading rate of  5 mm.min-1, up to 20% of strain, at 
room temperature. Samples were analyzed in the dry and wet conditions. For the wet condition, 
samples were immersed for 3 hours in PBS before being tested. The values reported represent an 
average of at least five testing specimens. Tensile force was taken as the maximum force in the force-
deformation curve. Tensile modulus was estimated from the initial linear section of the stress-strain 
curve. 
 
2.4.2 Nanoindentation Tests 
Nanoindentation tests were carried out to evaluate both sides of the composite membranes using a 
Nano Test (Micro Materials Ltd.) at room temperature. A Berkovich diamond indenter was used, with a 
three-sided pyramid geometry with a cross-sectional area in terms of contact depth of   25.24 cc hhA  . 
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A loading rate of 0.01mN/s was used until a maximum load of 10 mN was reached. At least 10 indents 
were made in random locations on each side of the membrane. 
 
2.5 Cell culture studies using hBMSC and hPDL 
Two types of cells were used in this study, namely human periodontal ligament cells (hPDL) and 
human bone marrow stromal cells (hBMSC). Both cells types were collected from 2 different donors.  
PDL cells were obtained from human third molar according to the following procedure. After 
extraction, the teeth were washed three times for 10 minutes in PBS with 100units/mL penicillin and 
streptomycin. PDL tissue was scraped from the middle third of the root with a scalpel blade, to avoid 
contamination by epithelial or pulpal cells. The freed portions of the periodontal ligament were minced 
and transferred to a small culture flask, filled with 5 mL alpha minimal essential medium (α-MEM, 
Gibco) with 10% v/v fetal calf serum (FCS, Gibco), 50 mg/mL ascorbic acid (Sigma), 10-8 M 
dexamethasone (Sigma), 50 mg/mL gentamycin (Gibco) and 10 mM sodium β-glycerophosphate 
(Sigma). Medium was refreshed every 2 to 3 days. Cells were cultured at 37°C in a humidified 
atmosphere of 5% CO2 and medium was replaced every 2 to 3 days. Upon reaching confluence, cells 
were released with trypsin/EDTA (0.25% w/v crude trypsin and 1 mM EDTA (pH 7.2)) and sub-cultured 
for 2 passages in standard culture flasks. The cells were then frozen in liquid nitrogen until used for the 
experiments. 
Human BMSCs were isolated from bone blocks of human iliac crest biopsies of donors. The biopsies 
were discarded tissues during standard surgical procedures at Radboud University Nijmegen Medical 
Center (Nijmegen, The Netherlands). The bone blocks were cut into small pieces and subsequently 
placed in a 50mL tube to which 20mL alpha-minimal essential medium (α-MEM) was added. After that 
the tube was shaken vigorously and the medium with cells was collected. This procedure was repeated 
several times. The collected medium with cells was plated in culture flasks (T175; Greiner Bio-one) and 
expanded in Proliferation Medium. Cells were characterized and showed stem cells phenotype. 
Additionaly, a multipotential differentiation test was applied, demonstrating their stem cells capacity. 
Cells were cultured at 37°C in a humid atmosphere with 5% CO2 and its passage was performed at 80% 
confluence using trypsin EDTA (Gibco). After the first generation, cells were plated at a density of 5000 
cells/cm2 in culture flasks (T175). The culture medium was changed twice a week. 
Cells from passage 3 (hBMSC) and 5 (hPDL) were used in the biological experiments. The 
composition of both proliferation and osteogenic medium, for both cell types, is described in Table2.1: 
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Table 2.1 – Proliferative and osteogenic medium composition. 
 Cell type 
hBMSC hPDL 
M
ed
iu
m
 
P
R
O
LI
FE
R
AT
IV
E 
-MEM  (Gibco) 
15% human FBS (Greiner Bio-one) 
1% Penicillin Streptomycin (Gibco-BRL) 
1% L-Glutamine (L-Glutamine) 
1% Ascorbic acid (Sigma) 
(1% of volume added to each cell culture flask) bFGF 
-MEM  (Gibco) 
10% FBS (Greiner Bio-one) 
1%  Penicillin Streptomycin (Gibco-BRL) 
O
ST
EO
G
EN
IC
 
-MEM  (Gibco) 
15% human FBS (Greiner Bio-one) 
1%  Penicillin Streptomycin (Gibco-BRL 
1% L-Glutamine (L-Glutamine) 
1% Ascorbic acid (Sigma) 
1% -glycerolphosphate (Sigma) 
1% Dexamethasone (Sigma) 
-MEM  (Gibco) 
10% FBS (Greiner Bio-one) 
1% Penicillin Streptomycin (Gibco-BRL) 
1% Ascorbic acid (Sigma) 
1% -glycerolphosphate (Sigma) 
1% Dexamethasone (Sigma) 
 
2.5.1 Cell Seeding 
Metal rings (15 mm x 3 mm) were glued to the membrane samples to keep them in the solution, 
with RTV Silicone Adhesive (Nusil, Silicone Technology, USA, MED-1037). The gluing of the rings to the 
membranes arose from the need to firm the membranes to the well’s bottom, do not allowing their 
winding neither fluctuation and, at the same time, guaranteeing an equal cell culture area for every 
sample. The cells were seeded directly on the membranes surface. For the BG group, cells were seeded 
on the side which contains BG particles. Once that the surface of the top side of PDLLA/BG 
membranes just contains pure polymer, is smooth and identical to the surface of PDLLA membranes 
(as it was already proved with previous characterization studies), they were considered as the same 
group in this experiment. 
Prior to cell seeding, the samples were sterilized with 70% (v/v) ethanol for 60 minutes and then 
washed three times immersed in PBS. The samples were placed in 25-well plates and soaked in cell 
culture medium overnight.  After removing the culture medium, 50 μL of a cell suspension with a 2.0 x 
104/sample cell density, was seeded onto the surface of each sample.  After incubation for 4 hours at 
37°C in a 5% CO2 atmosphere incubator, osteogenic medium (specific for each cell type) was added to 
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the seeded samples, according to the type of assay performed. On the control groups, cells were 
seeded directly on the well-plates and osteogenic medium was added immediately. 
 
2.6 Cell Adhesion, Proliferation and Metabolic Activity 
2.6.1 DNA content 
For DNA quantification and cell proliferation evaluation, Quant-iT™ PicoGreen® dsDNA reagent was 
chosen due to its simple reading, ultra sensitivity, high precision and accuracy. [2] PicoGreen is an 
ultrasensitive fluorescent nucleic acid which stains double stranded (ds) DNA in solution. 1xTris-EDTA-
working solution consists of a 20x diluted stock with DNAse-free water. The PicoGreen stock had to be 
diluted 200x on the day of measuring with 1x Tris-EDTA to make a PicoGreen working solution. To 
generate a standard curve, serial dilutions of the dsDNA stock were made.  
After the different experimental time points, medium was removed from the wells and the samples 
were washed twice with PBS. The analysis was performed on the supernatant of the substrates after 
day 1, 3, 7, 14 and 28 of culture. Cells were lysed using milliQ with subsequent sonification for 10 
minutes between two cycles of freeze/thaw from -80°C. The supernatant was stored at -20°C until 
further analysis. A PicoGreen dsDNA Quantification Kit (Molecular Probes, Eugene, USA) was used 
according to manufacturer’s instructions. The analysis was performed on the supernatant of the 
substrates on day 1, 3, 7 and 28. The standard DNA samples were prepared according to Table 2.2. To 
each 100 L sample, 100 L PicoGreen working solution was added. The samples must incubate for 
2-5 minutes at room temperature, in the dark. After incubation, the fluorescence was measured on a 
fluorescence cuvette reader (microplate fluorescence reader, Bio-Tek, Winooski, USA) with a 485 nm 
excitation filter and a 530 nm emission filter. 
 
Table 2.2 – Standard curve values for PicoGreen dsDNA Quantification, proliferation assay. 
 ng/mL Opl. A, L TE-buffer   ng/mL Opl. B, L TE-buffer 
1 2000  100   0   6 100  100 0 
2 1000  50 50   7 50  50 50 
3 500  25 75   8 25  25 75 
4 250  12.5 87.5  9 12.5 12.5 87.5 
5 125  6.25 93.75  10 6.25 6.25 93.75 
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2.6.2 Alamar Blue® staining 
AlamarBlue® staining (Invitrogen) requires minimal handling and incorporates a nontoxic reagent 
allowing continuous monitoring of cell proliferation and metabolic activity on the same samples using 
fluorescence observation. [3] Cell metabolic activity was measured according to the instructions of the 
manufacturer. A solution was made with AlamarBlue and culture medium in a proportion 1:9 (v/v) and 
was placed at 37°C for 5 minutes. The medium was removed from wells and replaced with the solution. 
Plates were incubated (37°C and 5% CO2) for 4 hours. After incubation, 200 µL of each sample solution 
was transferred to 96-well plates (Greiner Bio-one). Fluorescence was measured using a microplate 
reader (FL 600; Bio-Tek) at 570 nm. The assay was performed on day 1, 3, 7 and 28 of culture. 
 
2.6.3 Scanning Electron Microscopy (SEM) observation 
Adhesion of both cell types (hBMSC and hPDL) on membranes was analyzed by SEM (n=2). After 
day 3 and day 28 timepoints, cells were fixed in 2% v/v glutaraldehyde in 0.1 M sodium-cacodylate 
buffered solution, for 5 minutes. Cells were rinsed in cacodylate buffered solution, dehydrated in a 
series of ethanol dilutions in water (70%, 80%, 90%, 96% and 100% (v/v)), 1 hour in each, and dried in 
tetramethylsilane (TMS, Merck) to air. Finally, specimens were sputtercoated with a thin layer of gold, 
and examined in a JEOL 6310 scanning electron microscope.  
 
2.7 Cell Differentiation and Mineralization 
2.7.1 Alkaline Phosphatase Activity Measurements (ALP) 
Alkaline phosphatase is a cell surface glycoprotein that functions as a marker in the osteoblastic 
differentiation in vitro. Appearing in the beginning of the process, this marker produces its peak levels 
(maximum reached in activity per cell basis) with osteoblast maturation [4] and starts to reduce its 
expression and activity in the last states, with the progress of mineralization phase. [5; 6] This transition 
is a positive indication of the transient character of a cell line osteoblastic differentiation. [7] 
The same supernatants as used for PicoGreen assay were also used to measure alkaline 
phosphatase (ALP) activity (Sigma). To each 80 L of the sample, 20 L of 0.5M Alkaline Buffer 
(Sigma, cat#A9226) was added. Thereafter 100L substrate solution 5mM paranitrophenylphosphate 
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(PNP, Sigma, cat#P5994) was added to each well. After 60 minutes of incubation at 37C, 100 L 
stop solution (0.3M NaOH) was added to each well. Finally, ALP activity was measured at 405 nm using 
an ELISA microplate reader (Bio-Tek Instruments Inc, USA). 
Alkaline Phosphatase produced by the cells cleaves the phosphate ion from the substrate, p-
nitrophenyl phosphate. The resulting p-nitrophenol can be measured colorimetrically by the addiction of 
an alkaline solution. The quantity of p-nitrophenol liberated from the substrate can be determined by 
comparison to a curve generated from known concentrations of p-nitrophenol standards. A standard 
curve was made (Table 2.3 and 2.4). 
 
Table 2.3 – Needed solutions and respectively reagents and preparation instructions. 
Solutions Reagents and Instructions 
Buffer solution 0.5M 2-amino-2-methyl-1-propanol(AMP); Stock 1.5M diluted to 0.5M 
Substrate solution 
5 mM paranitrophenylphosphate (PNP; MW=263.1): 1.315 mg 
paranitrophenylphosphate/1mL buffersolution. (= 50 mg/38mL) 
Stop solution 0.3M NaOH (MW=40): 3 gram NaOH solute in 250 mlLMilliQ 
Standard curve: 
4-nitrophenol: (MW=139) 
 
Stock 10 mM: 13.9 mg/10mL buffer 
Before use: add 25L stock to 975L buffer: 250M 4- nitrophenol (NP) 
 
 
Table 2.4 – Standard curve values for ALP assay. 
nmol 250 μM 4-NP Buffer  nmol 250 μM 4-NP Buffer 
25 100 -  7.5 30 70 
20 80 20  5 20 80 
15 60 40  2.5 10 90 
10 40 60  Blank - - 
 
2.7.2 Von Kossa Staining 
Cells were fixed with 2% glutaraldehyde, stained with fresh 5% silver nitrate (AgNO3), washed with 
distilled water, developed with 5% sodium carbonate (Na2CO3) in 25% formalin, and fixed with 5% 
sodium thiosulphate (Na2S2O3). Stained samples were observed under a Leica MZ12 stereomicroscope 
and images were captured. 
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2.7.3 Ca Content 
Calcium complexes with o-cresolphthalein complexone (OCPC). At pH 10-12 calcium yields a red 
complex with OCPC. The color intensity of the purple complex formed is directly proportional to the 
calcium concentration. The complex is stabilized by KCN, thereby eliminating interference from heavy 
metals. [8] Calcium content was assessed after 21 and 28 days of culture to obtain information about 
mineralized matrix formation. The samples were rinsed twice with milliQ. 1 mL of acetic acid was added 
to each sample. The samples were incubated overnight under vigorous constant shaking and the acetic 
acid with the diluted calcium was frozen and kept at -20C, until further investigation. After thawing, the 
calcium content was determined using the OCPC method. Optic density was read with an ELISA reader 
(Bio-Tek Instruments Inc, USA) at a wavelength of 570 nm. Bare membranes were also assessed in 
order to further exactly quantify and distinguish cellular from acellular mineralization on the 
membranes. 
 
2.8 Statistical Analysis 
The biological tests were performed twice, with exception for Von Kossa. Each time with different 
donors, every sample was measured in triplicate. All the other procedures were performed just once, in 
duplicate for Von Kossa and SEM, in triplicate for the other ones. All results are presented as mean ± 
standard deviation. Statistical analysis of experimental data was performed using an unpaired ordinary 
ANOVA with standard parametric methods. Calculations were performed in InStat (v. 3.0 GraphPad 
Software Inc, San Diego, CA). Statistical significance was set to p-value ≤ 0.1 (*), to p-value ≤ 0.01 (**) 
and to p-value ≤ 0.001 (***). 
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Abstract 
In the treatment of periodontal defects, composite membranes might be applied to protect the 
injured area and simultaneously stimulate tissue regeneration. This work describes the development 
and characterization of poly(D,L-lactic acid)/Bioglass® (PDLLA/BG) membranes with asymmetric 
bioactivity, prepared by an adjusted solvent casting method that promoted a non-uniform distribution of 
the inorganic component along the membrane thickness. We hypothesized that the presence of BG 
microparticles could enhance structural and osteoconductivity performance of pure PDLLA membranes. 
In vitro asymmetric bioactive behavior (precipitation of an apatite layer upon immersion in simulated 
body fluid just on the BG rich face), SEM observation, FT-IR, swelling, weight loss and mechanical 
properties of the developed biomaterials were evaluated. Cell behavior on the membranes was 
assessed using both human bone marrow stromal cells and human periodontal ligament cells. SEM 
images, DNA content and metabolic activity quantification revealed an improved cell adhesion and 
proliferation on the composite membranes. Composite membranes also stimulated cell differentiation, 
mineralization, and production of extracellular matrix and calcium nodules, suggesting the positive 
effect of adding the bioactive microparticles in the PDLLA matrix. The results indicate that the proposed 
asymmetric PDLLA/BG membranes could have potential to be used in guided tissue regeneration 
therapies or in orthopaedic applications, with improved outcomes. 
 
Keywords: PDLLA, Bioglass®, membrane, periodontal ligament, tissue engineering.  
CHAPTER III. Asymmetric PDLLA Membranes Containing Bioglass® for Guided Tissue Regeneration 
44 
1| Introduction 
Periodontitis is a disease that destroys the tooth-supporting tissues, including the alveolar bone, 
periodontal ligament (PDL) and cementum. This is the major cause of tooth loss in human adults. [1] 
The treatment of periodontal defects can be a complex process and usually involves surgical 
intervention. However, periodontal defects, if left empty after open flap debridement, are filled with 
epithelial and fibroblasts, which are the first cell to reach the defect area, generating a core of fibro-
epithelial tissues that does prevents the occurrence of an adequate regeneration process of the 
periodontal tissues. [2] 
In this context, Guided Tissue Regeneration (GTR) strategies consist in the application of a 
membrane that acts as a physical barrier to protect the defect site, preventing the epithelial cells, 
fibrous and gingival connective tissues to reach the injured area. The creation of segregated space for 
the invasion of blood vessels and osteoprogenitor cells protects against the growth of non-osteogenic 
tissues. This procedure favors the regeneration of lost and damaged tissue since it promotes cell 
repopulation of the periodontal ligament and adjacent alveolar bone. However, acting solely as physical 
barriers is a limitation on the clinical effect of these membranes, since they provide no osteoconductive 
effects and their thus enabling only minor contributions for new cementum and bone formation, which, 
by definition, is not true periodontal tissue regeneration. [3] Each side of an implanted membrane is in 
contact with a distinct biological environment, in which the osteointegration should be ideally promoted 
just in one of the faces. Nevertheless, this asymmetric bioactive behaviour is almost inexistent in 
currently used GTR membranes and represents a possible challenge towards the development of 
innovative systems for the regeneration of periodontal tissues. 
GTR membranes can be obtained from natural or synthetic materials, either bioabsorbable or 
nonresorbable. Degradability is one of the most important requirements for GTR membranes and 
intends to avoid second surgical removing procedure. Natural resorbable collagen membranes have 
been widely used, not just because collagen is concretely one of the components of the alveolar bone 
and periodontal ligament but also because this material meets almost all the criteria required. [4] 
Collagen, however, presents some drawbacks such as its fast resorption rate, cytoxicity and xenogenic 
origin, poor mechanical strength and fast biodegradation by enzymatic activity. [4; 5] In order to avoid 
these undesirable characteristics, maintaining the desirable ones, synthetic materials have been more 
frequently used, predominantly those from the poly(α-hydroxyesters) family. [6] The chemical properties 
of these polymers allow its hydrolytic degradation and the elimination of the resulting products by 
natural pathways. [7] Moreover their processing is easy compared to other polymers and the variety of 
existent molecular weights and copolymers permits a wide range of physical, mechanical and 
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degradation rate related adjustments. Poly(D,L-lactic acid), PDLLA, is an amorphous polymer, with 
interesting mechanical properties and with degradation times in the order of 12 to 16 months. [8] It 
exhibits excellent biocompatibility in vivo, high mechanical stability and the possibility to be combined 
with drugs. [9-11] Nevertheless, PDLLA is not osteoconductive. Among different strategies that could be 
used to improve bioactivity in polymeric systems [12], the combination of osteoconductive inorganic 
particles has been widely used [7]. Bioglass® is a well known bioactive ceramic and has the ability to 
enhance the osteoblast activity and attachment between the biomaterial and the surrounding bone 
tissue, possibiliting the bone growth on the materials surface. Furthermore its dissolution products can 
control the gene expression in order to control the osteogenesis and consequently the production of 
growth factors [8], as well as counteracting the acidic degradation of the poly(α-hydroxyesters) providing 
a pH buffering effect. [13; 14] 
In this work, Bioglass® microparticles were compounded with a PDLLA membrane, using a solvent 
casting methodology. The conditions were optimized for the preparation of membranes exhibiting 
preferentially the BG in one of the sides of the membrane. It is envisioned that, upon implantation, the 
membrane side rich in BG could be faced to the defect side in which bone ingrowth should be 
stimulated while the more hydrophobic PDLLA rich side should act mainly as a barrier to avoid the 
invasion of soft tissue. Thus, this design would meet the current big challenge abovementioned for GTR 
in this specific area: the asymmetric bioactivity. Therefore, purpose of this work was to characterize 
some relevant properties of the developed membranes and to evaluate their biological performance, 
using two distinct cell types: human bone marrow stromal cells (hBMSC) and human periodontal 
ligament cells (hPDL). 
 
 
2| Materials and methods 
2.1 Materials 
Poly(D,L-lactic acid) (PDLLA), (Mn= 31750 and Mw= 100000) with an inherent viscosity of 1.87 dL/g 
was purchased from Purasorb® (PURAC Biochem, The Netherlands) and was used as received. The 
45S5 Bioglass®, with the composition: 45 SiO2, 24.5 CaO, 24.5 Na2O and 6.0 P2O5 in wt%, was 
supplied by US Biomaterials Corp. (Florida, USA). The particle size of the Bioglass® particles (BG), 
measured by laser scattering analysis (Coulter LS 100 particle size analyzer), was found to be lower 
than 20 μm. All the other reagents and solvents used were of reagent grade and were used without 
further purification. 
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2.2 Preparation of PDLLA and PDLLA/Bioglass® Membranes 
All the membranes were prepared based on a solvent casting technique. The PDLLA films were 
prepared by dissolving 0.50 g of PDLLA in 30 mL of chloroform. After total dissolution, the solution was 
transferred to a Petri dish with 9 cm of diameter and covered with an aluminium sheet. The Petri dish 
was settled in a horizontal position to facilitate the formation of a cast film with uniform thickness. The 
assembly was kept in a hood for 24h, and chloroform was allowed to evaporate at a very slow rate. 
Then, the films were vacuum dried for 48h at 40ºC. 
The PDLLA/BG membranes were prepared in the exact same process as the pure PDLLA 
membranes. The PDLLA/BG dispersions were prepared by dissolving 0.40 g of PDLLA in 30 mL of 
chloroform. After total dissolution, 0.10 g of Bioglass® was dispersed in the above solution. During 
solvent evaporation the particles were deposited by gravity to the bottom side, creating an asymmetric 
of 80/20 PDLLA/BG membrane along the thickness. 
 
2.3 Bioactivity Tests 
For the in vitro bioactivity tests an acellular simulated body fluid (SBF) (1.0x) with ions concentration 
nearly equal to human blood plasma was prepared [15]. Sample membranes of 20x15 mm2 were cut 
from the original processed films for the bioactivity tests. Three replicates for each sample were 
immersed in 45 mL SBF for 2, 5, 7, 14 and 21 days at 37º C. After being removed from SBF the 
membranes were gently rinsed with distilled water and dried at room temperature. 
 
2.4 Physico–chemical Characterization 
2.4.1 Scanning Electron Microscopy (SEM) 
Qualitative information of the morphology of PDLLA and PDLLA/BG membranes surfaces, before 
and after the immersion in SBF, was obtained using a Scanning Electron Microscope, SEM (Nova 
NanoSEM 200-FEI Company), at an accelerated voltage of 5 kV. Before being observed by SEM, the 
membranes were gold coated using a Hitachi coating unit IB-2 coater at 6 mA. 
 
2.4.2 Fourier Transform Infrared Spectroscopy (FTIR) 
The possible formation of a CaP layer onto the surface of polymeric membranes incorporating the 
microparticles after 14 days soaking in SBF, was analysed by infrared spectroscopy where the 
background noise was calibrated with pure KBr data. Also, each side of the composite membrane were 
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analysed with the attenuated total reflection accessory. Spectra were recorded in an IR Prestige 21 FTIR 
spectrophotometer with the attenuated total reflection accessory (128 scans, resolution 4 cm -1) in the 
spectral range 2000-400 cm-1. 
 
2.4.3 Swelling Properties 
The water sorption capacity of the membranes was determined by swelling the samples in 
phosphate buffered saline solutions (PBS, Gibco) at pH 7.4 for upt to 4 months at 37°C. The initial 
weight of each membrane (approximately 10×10 mm2) was measured with an analytical balance 
(Scaltec, Germany) before immersion in the PBS for several pre-determined time intervals (5 min, 30 
min, 1 h, 1 day, 7, 14, 22, 28 days, then 6, 8, 12 weeks and finally 4 months) and immediately 
weighted after the removal of excess of water by lying the surfaces on a filter paper (Whatman 
Pergamyn Paper, 100×100 mm2). The swelling ratio (SR) was calculated using the following equation 
(1): 
    
     
  
            (1) 
 
Where    and    are the weights of the samples at the swelling state and at the dry state, 
respectively. 
 
2.4.4 Degradation Test 
The degradation of both membranes (with or without BG microparticles) was evaluated by 
immersing samples (with known weights and approximately 10×10 mm2) in PBS, at pH 7.4 for 4 
months at 37°C. At pre-determined time intervals (5 min, 30 min, 1 h, 1 day, 7, 14, 22, 28 days, then 
6, 8, 12 weeks and, finally, 4 months) samples were removed from the solution and washed with 
distilled water three times for the removal of salts. The samples were dried at room temperature and 
then weighted with an analytical balance (Scaltec, Germany). The following equation (2) was used to 
calculate the percentage weight loss (%WL) of the samples: 
 
     
     
  
                        (2) 
 
Where    is the initial dry weight of the sample and    is the weight of the dry sample after 
incubation in the PBS solution. 
CHAPTER III. Asymmetric PDLLA Membranes Containing Bioglass® for Guided Tissue Regeneration 
48 
2.5 Mechanical Characterization 
2.5.1 Mechanical properties 
The tensile properties were determined using an INSTRON 4505 Universal Machine (Instron Int. 
Ltd., USA) equipped with a 1 kN load cell, with a loading rate of  5 mm.min-1, up to 20% of strain, at 
room temperature. Samples were analyzed in the dry and wet conditions. For the wet condition, 
samples were immersed for 3 hours in PBS before being tested. The values reported represent an 
average of at least five testing specimens. Tensile force was taken as the maximum force in the force-
deformation curve. Tensile modulus was estimated from the initial linear section of the stress-strain 
curve.  
 
2.5.2 Nanoindentation Tests 
Nanoindentation tests were carried out to evaluate both sides of the composite membranes using a 
Nano Test (Micro Materials Ltd.) at room temperature. A Berkovich diamond indenter was used, with a 
three-sided pyramid geometry with a cross-sectional area in terms of contact depth of   25.24 cc hhA  . 
A loading rate of 0.01mN/s was used until a maximum load of 10 mN was reached. At least 10 indents 
were made in random locations on each side of the membrane. 
 
2.6 Cell culture studies using hBMSC and hPDL 
Two types of cells were used in this study, namely human periodontal ligament cells (hPDL) and 
human bone marrow stromal cells (hBMSC). Both cells types were collected from 2 different donors.  
PDL cells were obtained from human third molar according to the following procedure. After 
extraction, the teeth were washed three times for 10 minutes in PBS with 100units/mL penicillin and 
streptomycin. PDL tissue was scraped from the middle third of the root with a scalpel blade, to avoid 
contamination by epithelial or pulpal cells. The freed portions of the periodontal ligament were minced 
and transferred to a small culture flask, filled with 5 mL alpha minimal essential medium (α-MEM, 
Gibco) with 10 % v/v fetal calf serum (FCS, Gibco), 50 mg/mL ascorbic acid (Sigma), 10-8 M 
dexamethasone (Sigma), 50 mg/mL gentamycin (Gibco) and 10 mM sodium β-glycerophosphate 
(Sigma). Medium was refreshed every 2 to 3 days. Cells were cultured at 37°C in a humidified 
atmosphere of 5% CO2 and medium was replaced every 2 to 3 days. Upon reaching confluence, cells 
were released with trypsin/EDTA (0.25% w/v crude trypsin and 1 mM EDTA (pH 7.2)) and sub-cultured 
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for 2 passages in standard culture flasks. The cells were then frozen in liquid nitrogen until used for the 
experiments. 
Human BMSCs were isolated from bone blocks of human iliac crest biopsies of donors. The biopsies 
were discarded tissues during standard surgical procedures at Radboud University Nijmegen Medical 
Center (Nijmegen, The Netherlands). The bone blocks were cut into small pieces and subsequently 
placed in a 50mL tube to which 20mL alpha-minimal essential medium (α-MEM) was added. After that 
the tube was shaken vigorously and the medium with cells was collected. This procedure was repeated 
several times. The collected medium with cells was plated in culture flasks (T175; Greiner Bio-one) and 
expanded in proliferation medium. Cells were characterized and showed stem cells phenotype. 
Additionaly, a multipotential differentiation test was applied, demonstrating their stem cells capacity. 
Cells were cultured at 370C in a humid atmosphere with 5% CO2 and its passage was performed at 80% 
confluence using trypsin EDTA (Gibco). After the first generation, cells were plated at a density of 5000 
cells/cm2 in culture flasks (T175). The culture medium was changed twice a week. 
Cells from passage 3 (hBMSC) and 5 (hPDL) were used in the biological experiments. 
 
2.6.1 Cell seeding 
Metal rings (15 mm x 3 mm) were glued to the membrane samples to keep them in the solution, 
with RTV Silicone Adhesive (Nusil, Silicone Technology, USA, MED-1037). Prior to cell seeding, the 
samples were sterilized with 70% (v/v) ethanol for 60 minutes and then washed three times immersed 
in PBS. The samples were placed in 25-well plates and soaked in cell culture medium overnight.  After 
removing the culture medium, 50 μL of a cell suspension with a 2.0 x 104/sample cell density, was 
seeded onto the surface of each sample.  After incubation for 4 hours at 37°C in a 5% CO2 atmosphere 
incubator, osteogenic medium (specific for each cell type) was added to the seeded samples, according 
to the type of assay performed. On the control groups, cells were seeded directly on the well-plates and 
osteogenic medium was added immediately. 
 
2.7 Cell Adhesion, Proliferation and Metabolic Activity 
2.7.1 DNA content 
After the different experimental time points, medium was removed from the wells and the samples 
were washed twice with PBS. The analysis was performed on the supernatant of the substrates after 
day 1, 3, 7, 14 and 28 of culture. Cells were lysed using milliQ with subsequent sonification for 10 
minutes between two cycles of freeze/thaw from -80°C. The supernatant was stored at -20°C until 
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further analysis. A PicoGreen dsDNA Quantification Kit (Molecular Probes, Eugene, USA) was used 
according to manufacturer’s instructions. To each 100 L sample, 100 L PicoGreen working solution 
was added. The samples must incubate for 2-5 minutes at room temperature, in the dark. After 
incubation, the fluorescence was measured on a fluorescence cuvette reader (microplate fluorescence 
reader, Bio-Tek, Winooski, USA) with a 485 nm excitation filter and a 530 nm emission filter. 
 
2.7.2 Alamar Blue® staining 
Cell metabolic activity was measured using AlamarBlue® staining (Invitrogen) according to the 
instructions of the manufacturer. A solution was made with AlamarBlue and culture medium in a 
proportion 1:9 (v/v) and was placed at 37°C for 5 minutes. The medium was removed from wells and 
replaced with the solution. Plates were incubated (37°C and 5% CO2) for 4 hours. After incubation, 200 
µL of each sample solution was transferred to 96-well plates (Greiner Bio-one). Fluorescence was 
measured using a microplate reader (FL 600; Bio-Tek) at 570 nm. The assay was performed on day 1, 
3, 7, 14 and 28 of culture. 
 
2.7.3 Scanning Electron Microscopy (SEM) observation 
Adhesion of both cell types (hBMSC and hPDL) on membranes was analyzed by SEM (n=2). After 
day 3 and day 28 time points, cells were fixed in 2% v/v glutaraldehyde in 0.1 M sodium-cacodylate 
buffered solution, for 5 minutes. Cells were rinsed in cacodylate buffered solution, dehydrated in a 
series of ethanol dilutions in water (70%, 80%, 90%, 96% and 100% (v/v)), 1 hour in each, and dried in 
tetramethylsilane (TMS, Merck) to air. Finally, specimens were sputtercoated with a thin layer of gold, 
and examined in a JEOL 6310 scanning electron microscope.  
 
2.8 Cell Differentiation and Mineralization 
2.8.1 Alkaline Phosphatase Activity Measurements (ALP) 
The same supernatants as used for PicoGreen assay were also used to measure alkaline 
phosphatase (ALP) activity (Sigma). To each 80 L of the sample, 20 L of 0.5M Alkaline Buffer 
(Sigma, cat#A9226) was added. Thereafter 100 L substrate solution 5mM paranitrophenylphosphate 
(PNP, Sigma, cat#P5994) was added to each well. After 60 minutes of incubation at 37C, 100 L 
stop solution (0.3M NaOH) was added to each well. Finally, ALP activity was measured at 405 nm using 
an ELISA microplate reader (Bio-Tek Instruments Inc, USA). 
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2.8.2 Von Kossa Staining 
Cells were fixed with 2% glutaraldehyde, stained with fresh 5% silver nitrate (AgNO3), washed with 
distilled water, developed with 5% sodium carbonate (Na2CO3) in 25% formalin, and fixed with 5% 
sodium thiosulphate (Na2S2O3). Stained samples were observed under a Leica MZ12 stereomicroscope 
and images were captured. 
 
2.8.3 Ca Content 
Calcium content was assessed after 21 and 28 days of culture to obtain information about 
mineralized matrix formation. The samples were rinsed twice with milliQ. 1 mL of acetic acid was added 
to each sample. The samples were incubated overnight under vigorous constant shaking and the acetic 
acid with the diluted calcium was frozen and kept at -20C, until further investigation. After thawing, the 
calcium content was determined using the OCPC method. Optic density was read with an ELISA reader 
(Bio-Tek Instruments Inc, USA) at a wavelength of 570 nm. Bare membranes were also assessed in 
order to further exactly quantify and distinguish cellular from acellular mineralization on the 
membranes. 
 
2.9 Statistical Analysis 
All samples were measured in triplicate. Biological tests were performed twice, excepting Von Kossa. 
All results are presented as mean ± standard deviation. Statistical analysis of experimental data was 
performed using an unpaired ordinary ANOVA with standard parametric methods. Calculations were 
performed in InStat (v. 3.0 GraphPad Software Inc, San Diego, CA). Statistical significance was set to p-
value ≤ 0.1 (*), to p-value ≤ 0.01 (**) and to p-value ≤ 0.001 (***). 
 
 
3| Results and Discussion 
3.1 Membranes characterization 
3.1.1 Bioactivity, morphology and microstructure 
The surface morphology of PDLLA and PDLLA/BG membranes were analyzed using SEM – see Fig. 
3.1A. A flat, smooth, nonporous surface was observed on the PDLLA membranes with no evidence of 
surface irregularity (A1). Both upper and bottom faces of the composite membrane (see scheme in Fig. 
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1B) were also analyzed. The upper face of the composite PDLLA/BG 80/20 membrane is also smooth 
(B1) but the bottom face (C1) presents some asperities, homogeneously distributed in the surface 
corresponding to the BG particles that were preferentially deposited in this side of the membrane. The 
image suggests that the particles are well incorporated in the polymeric matrix. 
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Figure 3.1 – In vitro bioactivity tests of the developed membranes: (A) SEM micrographs of the surfaces of the PDLLA (A1) and PDLLA/BG 
membranes, from upper and bottom face (B1 and C1), before and after 2 days of immersion in SBF (A2, B2, C2). The scale bar represents 
50 μm. (B) Schematic design of the PDLLA/BG membrane, evidencing the distinct faces. (C) FT-IR spectra of both sides of the composite 
membrane: bottom face rich in BG (red line) and upper face exposing basically PDLLA (orange line). 
 
The bioactive character of the produced composite membranes was tested in vitro by immersing the 
materials in SBF – see evolution of the morphology of the surfaces in Fig. 3.1A. No Ca-P layer was 
formed on the surface of pure PDLLA membrane (A2) or of the upper face of the composite membrane 
(B2), even after 21 days of immersion in SBF. Only the membranes face enriched with BG presented a 
bioactive character, where an uniform ceramic layer could be detected after only 2 days of immersion 
in SBF (C2).  
The morphological analysis was complemented with FTIR – see Fig. 3.1C. The characteristic FTIR 
bands of the upper face are located at 750 and 865 cm-1 (CH band); 1042, 1090, 1138, and 1186 cm-1 
(=C–O stretch); 1375 cm-1 (CH2 wag); 1452 cm-1 (CH3 band) and 1751 cm-1 (C=O stretch, ester group) 
that are the characteristic bands of PDLLA [16]. The spectrum of the bottom face of the membrane 
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indicates the presence of BG particles: 867, 1454 cm-1 (CO32- bands); 1200-700 cm-1 (Si-O-Si bands) [17; 
18].  
 
3.1.2 Material stability properties 
In order to understand the behavior of the membranes in an aqueous environment, the weight loss 
– see Fig. 3.2 – and swelling ratio were measured up to 4 months.  
 
Figure 3.2 – Weight loss percentage of PDLLA and PDLLA/BG membranes, in PBS solution, at 37°C up to 120 days. Values are reported 
as mean ± SD (n=3). Statistically significant differences in the weight loss values of the PDLLA/BG membranes when compared to those 
of the pure PDLLA are indicated by (*) for p < 0.1, (**) for p < 0.01 and (***) for p < 0.001. 
 
The incorporation of BG particles has been reported to play an important role in polymer surface 
wettability [19]. Its introduction in polymer matrices can modify the surface and inclusively the bulk 
properties of the composite, by enhancing both hydrophilicity and water absorption [20]. In the system 
studied in this work, no significant swelling was observed in the membranes even when BG is 
incorporateds (data not shown). 
Within the time period analyzed the weight loss of the PDLLA membrane was not significant: after 
120 days of immersion in SBF, the weight loss was about 12%. For the case of the composite 
membrane we could detect a faster weight loss up to 50 days that could be related to the slow 
dissolution of the inorganic component. Such process is consistent with the event of the formation of an 
apatite layer upon immersion in SBF, discussed before. 
 
3.1.3 Mechanical properties 
Adequate mechanical integrity is known as an important requirement for membranes in guided 
tissue regeneration. Either to adapt the desired shape or to support the stresses of the surrounding 
native tissue at the site of implantation, membranes should be strong but flexible. [3] Tensile 
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mechanical tests were performed for the PDLLA and PDLLA/BG membranes. Both dry and wet 
specimen conditions were assessed; the last condition simulate better the behavior of these materials in 
the oral cavity environment. Representative stress-strain curves are shown in Fig. 3.3. Table 3.1 shows 
the maximum strain and stress obtained in these experiments as well as the tensile or Young modulus 
of the membranes. The addition of BG in the PDLLA membranes significantly reduced the maximum 
strain and a small reduction of the maximum stress could be also detected. Previous works reported 
also a reduction of the strength upon reinforcement in composites of poly(α-hydroxyesters). [21; 22] 
The behavior observed in the membranes may be due to the increase in pore size by introducing 
Bioglass® in the pure PDLLA matrix. Young modulus values were very similar between both types of 
membranes, in both dry and wet conditions. 
 
Figure 3.3 – Representative stress versus strain curves obtained for PDLLA and PDLLA/BG membranes 
in dry (solid lines) and wet (dashed lines) conditions. 
 
 
Table 3.1 – Young modulus, maximum strain and maximum stress of the PDLLA and PDLLA/BG membranes obtained in dry and wet 
conditions. Values are reported as mean ± SD. Statistically significant differences in the mechanical properties of the PDLLA/BG 
membranes when compared to those of the pure PDLLA are indicated by (*) for p < 0.1 and (**) for p < 0.01. 
 
 
 
YOUNG MODULUS (MPa) MAXIMUM STRAIN (%) MAXIMUM STRESS (MPa) 
 CONDITION DRY WET DRY WET DRY WET 
SA
M
P
LE
 PDLLA 713.7 ± 77.9 656.9 ± 38.1 166.2 ± 81.3 141.0 ± 94.1 26.2 ± 1.56 27.4 ± 1.38 
PDLLA/BG 743.3 ± 30.3 617.9 ± 38.8 21.9 ± 5.5 * 21.6 ± 11.4 * 17.7 ± 5.21** 23.1 ± 1.43 
 
No significant differences were observed between the dry and wet samples. Water can affect strongly 
the molecular wettability and the viscoelastic properties of poly(lactic acid) [23]. However, in the 
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membranes prepared in this work swelling was almost inexistent and no significant plasticization effect 
of water toke place, as reflected in the tensile mechanical properties at 37°C. 
Nanoindentation experiments were also performed in order to have more insights about the 
mechanical properties of both membranes surfaces. A series of load (P)-displacement (h) curves are 
shown in Fig. 3.4A. The hardness (H) was calculated by dividing the maximum load by the contact area 
  
    
 
  where Pmax is the maximum load applied during the indentation and A is the projected area of 
contact between the indenter and the sample. The slope of the unloading curve, dP/dh, provides a 
measure of the elastic moduli, E [24; 25]. Repeated experiments performed on the upper face of the 
membrane present load-depth curves very superimposed. The bottom face of the membrane presents a 
more heterogeneous surface that could explain the much more scattered ―bottom face‖ plots of Fig. 
3.4A.  
 
 
  
Figure 3.4 – Nanoindentation results obtained by cycled experiment: (A) Six different indents either for the upper face (UF) and the bottom 
face (BF) of the membrane and (B) hardness values for both sides of the membranes. There were no statistically significant differences (p 
> 0.05) observed between the parameters of the analyzed materials. 
 
 
 The nanoindentation curves show a greater resistance to deformation in the upper face than in the 
bottom face as indicated by how far the indenter was able to penetrate on each side of the membrane 
for the same maximum force. This resulted in different values of hardness (H) (Fig. 3.4B) that were 
higher for the upper side (≈250 MPa) than for the bottom side (≈5 MPa) of the composite membranes. 
Such difference could be ascribed to the more porous structure of the bottom side of the composite 
membrane. 
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3.2 In vitro hBMSC and hPDL cells culture 
3.2.1 Cell Adhesion, Proliferation and Metabolic Activity 
DNA content was quantified at different culture time points for both membranes – see Fig. 3.5A. A 
clear proliferation of both cell types onto the PDLLA and PDLLA/BG membranes was observed until 28 
days of culture. Significantly higher cell content was found in BG containing membranes seeded with 
hBMSC after 28 days of culture.  
Complementarily, cell metabolic activity was measured. As the values between different days for 
fluorescence intensity of Alamar Blue are not comparable, it was calculated a ratio between the 
composite and PDLLA membrane samples, in each time point – see Fig. 3.5B. Therefore, values above 
1 means higher metabolic activity for samples with BG than the ones without BG. Average cell growth 
and their metabolic activity was higher in the PDLLA/BG group than in the PDLLA group, for hBMSC. 
 
 
 
Figure 3.5 – Results obtained from DNA and Alamar Blue assays at 1, 3, 7, 14 and 28 days of culture: (A) DNA content, 
in ng/mL, of hBMSC and hPDL cells seeded onto each membrane type and controls (plastic cell culture in polystyrene), 
(B) metabolic activity ratio between the samples with and without BG (solid lines) for both cell types, where the border 
line (dashed orange line) is y=1. Values are reported as mean ± SD (n=3). (*) shows significant differences for p < 0.1, 
(**) for p < 0.01 and (***) for p < 0.001. 
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These enhanced hBMSC cells proliferation and metabolic activity showed by the PDLLA/BG 
membranes is in accordance with some previous studies [26; 27; 28] that reported the promotion of 
cell proliferation by Si and other released products from bioactive glasses. Sun et al. showed an 
enhanced metabolic activity of hBMSC on akermite ceramics verified trough Alamar Blue staining, 
which has a composition very similar to BG [29]. Other studies [30; 31; 32; 33; 34] reported the 
enhancement of osteoblast cell proliferation by the influence of BG particles corroborating the results 
herein obtained for PDLLA/BG membranes, using hBMSC. Higher concentrations of DNA were 
observed in BMSC’s cultured when 45S5 Bioglass® was added to a new ceramic based on 
hydroxyapatite compared to the pure material.[35] High contents of bioactive component may lead to a 
negative effect on cell behavior. For example, cell studies with scaffolds of PDLLA, containing different 
contents of BG (0.5 and 40 wt%) showed enhanced proliferation and ALP activity for the 5% ones [36]. 
Due to the subsequent augmented and prolonged ion release and increase of pH, the materials with the 
largest BG concentration appeared to fail. Exceptions have been also reported. For example, Wilda et al. 
obtained better results with PDLLA/BG 30 wt% comparing to 0 or even 5 wt% [37]. 
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Figure 3.6 – SEM micrographs of PDLLA and PDLLA/BG membranes after cultured with hPDL and hBMSC cells. The subscripts 
indicate the incubation time. 
 
PDLLA and PDLLA/BG membranes cultured with hBMSCs and hPDL cells were further studied 
using SEM – see Fig. 3.6. After 3 days of culture, hPDL cells spread perfectly on the PDLLA/BG 
membranes (B3). On day 28, there was a very dense extracellular matrix (ECM) deposition for both 
hBMSC and hPDL cells on PDLLA/BG membranes (B28 and D28), which hampered the distinction of the 
cells morphology and the examination of surface roughness in the material. Once that osteoblasts 
mature and start depositing ECM, this extended ECM is a signal of cell differentiation [38]. Still at this 
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time point, (C28) the adhesion of hBMSC could be detected, either spread in an elongated shape, 
polarized with lamellipodia (see (*) on inset image of C28) or in some cell agglomerates. Many studies 
have examined the ability of BG to enhance not just cell proliferation [39; 40] but also the ECM 
production [41], which is in accordance with these results. 
 
3.2.2 Cell Differentiation and Mineralization 
Alkaline phosphatase activity was measured to assess the osteogenic differentiation potential of the 
cells cultured in the developed membranes. The results obtained from this assay (Fig. 3.7) were 
normalized by the DNA content measured for the same sample. No detectable ALP activity could be 
seen during the first time points, being consistent with the undifferentiated state of the cells. After day 
14, and specially day 28, we can see significant ALP activity of the cells in the membranes. 
While some authors [26; 27] claim that the addition of BG particles has no effect on ALP activity of 
rat primary culture osteoblasts and murine osteoblasts, others state that this addition has stimulatory 
effects on the ALP activity of human primary osteoblasts [42], BAF cells [43; 37], and hBMSC [29].  At 
28 days of culture, higher ALP activity was detected for the composite membranes cultured with 
hBMSC, compared to the pure PDLLA membranes and even to the control group. This provides a clear 
indication of a more extended osteogenic differentiation of hBMSC on the PDLLA/BG composite 
membranes.  
 
 
Figure 3.7 – Alkaline phosphatase activity, normalized by the DNA content, of hBMSC and hPDL cells on PDLLA and PDLLA/BG 
membranes and controls(plastic cell culture in polystyrene) at 1, 3, 7, 14 and 28 days of culture. Values are reported as mean 
± SD (n=3). (*) shows significant differences for p < 0.1, (**) for p < 0.01 and (***) for p < 0.001. 
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In alignment with the ALP results, statistically significantly higher calcium content was found in the 
PDLLA/BG membranes (Fig. 3.8A). Von Kossa staining allowed observing the formation of 
mineralization nodules by hPDL cells on composite membranes, after 28 days of culture (Fig. 3.8B). No 
nodule formation was detected on PDLLA membranes (data not shown). It is also to note the fact that 
there was an increasing calcium deposition, over time (21 to 28th day), statistically significant for the 
hBMSc cells on composite membranes. 
These results are in accordance with other related studies. For example, a stronger and earlier 
calcium phosphate mineral formation in bioactive composites was observed for rat bone marrow cells 
[44]; faster nodule formation in porous bioactive glass scaffolds, as compared with control cultures [28]  
using human primary osteoblasts, among others previous studies [45; 46], demonstrating that BG 
causes an increase of calcium in the medium, which is a modulator of intracellular events. 
 
 
 
     
Figure 3.8 – Evaluation of the mineralization of hBMSC and hPDL cells on PDLLA and PDLLA/BG membranes and controls 
(plastic cell culture in polystyrene), after 21 and 28 days of culture: (A) Calcium content quantification and comparison 
between 21 and 28 days of incubation. (B) Calcium nodules formation, verified by Von Kossa staining at day 28 of 
incubation, on PDLLA/BG membrane cultured with hPDL cells. (C) Ratio of mineralization between seeded and bare 
membranes. Values are reported as mean ± SD (n=3). (*) shows significant differences for p < 0.1, (**) for p < 0.01 and 
(***) for p < 0.001. 
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It has been reported that bone nodule formation occurs when human bone-derived cells are cultured 
for extended periods of time in the presence of ascorbate and/or β-glycerophosphate (components 
present in the osteogenic medium used in this study) [47]. Bone nodules consist of differentiated 
osteoblasts, extracellular matrix, and associated minerals, and their formation characterizes a late stage 
of osteoblast differentiation [47], being a good index of osteogenesis in vitro [47; 48; 49]. However, it 
was previously demonstrated that calcified bone nodule formation can be detected as early as day 6 in 
culture on the bioactive glass, without either of the above supplements in the culture medium. [42] 
Both of these mineralization assays indicated that BG improved mineralization, complementing each 
other information. 
 
4| Conclusions 
The incorporation of BG in PDLLA membranes modified their physico-chemical and biological 
properties. The mechanical properties of the membranes were not significantly compromised with the 
introduction of BG. The asymmetric distribution of the BG particles along the thickness in the composite 
membrane permitted to induce a bioactive character in one of the sides of the membrane. The 
inorganic component had a positive impact in the adhesion, proliferation, differentiation and 
mineralization of hBMSC cells on PDLLA/BG membranes. Therefore, our results suggest that the 
obtained asymmetric bioactive PDLLA/BG 80/20 membrane, with osteoconductive properties in just 
one of the faces, could have potential use in the regeneration of distinct tissues, namely periodontal 
ligament and bone. 
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1| General Conclusions and Future Research 
A novel biocompatible and biodegradable membrane was obtained by combining poly(D,L-lactic 
acid), PDLLA, and microparticles of Bioglass®, BG, featuring an asymmetric bioactivity and a good 
integration, between the polymeric and inorganic fractions, in a 80/20 reason. The membranes were 
prepared in a single step, by a simple and viable adjusted solvent casting methodology. The asymmetric 
distribution of the bioactive BG particles was conferred during the processing of the membrane, in 
which, while solvent was evaporating, the particles were preferentially depositing by gravity to the 
bottom side. The incorporation of BG in the PDLLA membranes influenced their physico-chemical 
properties and, consequently, their biological properties. These properties were further evaluated, 
contributing to the understanding of the biological applicability of asymmetric composite membranes.  
Only the inorganic-rich face could promote the deposition of a bone-like apatite layer immersing the 
membrane in simulated body fluid, which occurred after 2 days just on the face containing BG, proving 
the asymmetric bioactivity of the PDLLA/BG membranes. The good impregnation of the BG particles on 
the membranes conferred a homogeneous roughness to their surface and improved porosity. As a 
result, the particles were more exposed and could be more easily dissolved accelerating the 
degradation rate, and simultaneously the weight loss. No significant differences between PDLLLA and 
PDLLA/BG membranes were found for swelling and mechanical tensile behaviors, revealing this to be a 
stable combination. These parameters are passive of being tailored, once that polymer/bioglass ratio 
could be optimized according to specific applications. 
Attending to the distinct biological environments in which the two sides of the membranes are in 
contact upon implantation, two different cell cultures were selected for the biological assessment in this 
study. Human bone marrow stromal cells, hBMSC, and human periodontal ligament cells, hPDL, were 
seeded in osteogenic medium on the membranes surface. Bioactive character of composite 
membranes seemed to significantly favor cell adhesion, which was reflected in higher cell proliferation 
and metabolic activity values. An enhancement on cell differentiation was further detected for both cell 
types, as well as a promoted mineralization, an extended extracellular matrix and calcium nodule 
formation, due to the bioactive character of the BG added. All the biological properties were improved 
with significant differences comparing to the controls (plastic cell culture) and with a higher differential 
for hBMSC. 
The new asymmetric composite PDLLA/BG membrane is expected to have potential applications in 
guided tissue regeneration. Structural and biological performances presented in this study by this 
membrane showed to be advantageous and possibly profitable applicable to a wide range of periodontal 
defects and additionally bone deficiencies that restrain dental implants application. Considering that 
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periodontal diseases represent the major cause of tooth loss in adults and that, subsequently, the 
Implantology cases are exponentially increasing, such new approaches are essential to supply the 
mentioned needing.  
In vitro, osteoblast differentiation is a gradual process represented by a temporal expression of 
genes and characterized by three principle periods: proliferation, extracellular matrix 
production/maturation, and mineralization, with mRNA peak levels defining the transition between 
periods. [1] Bone tissue contains several non-collagenous proteins, such as osteocalcin (OCN) and 
alkaline phosphatase (ALP), which distinguish it from other types of tissues. ALP is the most widely 
recognized marker for osteoblast activity, expressed in culture by the osteogenic cells, namely hBMSC, 
[2; 3] and its metabolic activity was assessed in the current study. However, a further evaluation of 
gene expression would be interesting and valuable to investigate the differentiation progress on the 
PDLLA/BG membranes, mainly, since OCN is a marker that appears late during osteoblast 
differentiation and characterizes mature cells of the osteoblastic lineage (e.g. osteocytes), actively 
producing mineralized tissue. [1] A RT-PCR (real-time polymerase chain reaction) procedure could be a 
smart choice to help in the diagnosis of differentiation evolution. 
Another interesting feature to explore would be the PDLLA excellent ability to combine with drugs like 
growth and differentiation factors, establishing a locally acting drug-delivery system. [4] Moreover the 
Bioglass® dissolution products (particularly the 45S5 composition) could upregulate the gene 
expression that control osteogenesis and the growth factors production [5]. Such gene expression 
control and the use of growth factors are indicated as promising approaches in periodontal therapy. [6] 
Cleverly combined with the PDLLA/BG asymmetric membranes, these approaches might positively 
manipulate the osteoblastic differentiation,  inducing selective cellular repopulation of periodontal 
defects, consequently resulting in a substantial increase on bone formation. Prospecting better clinical 
outcomes, this combination could contribute with an enhancement in long-term complete periodontal 
regeneration. 
The data demonstrated in this study derived from an in vitro experimental model, which constitutes 
by itself a limitation. Therefore, the biocompatibility, both in situ and ex vivo, of the current membranes 
material is still unclear in human oral cavity. In order to clarify these points, supplementary and 
complementary, the development of animal experiment studies should be further employed. Despite of 
the referred limitation, the results obtained suggests the PDLLA/BG membranes as a great promising 
biomaterial for guided tissue regeneration. 
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